ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000130.1|Pyrrolomycin_1 # 1 # 459 # 1 # ID=1_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.693	BGC0000130.1|Pyrrolomycin_1 	1	459	+	Loose	575	23.483	ORN-6	35.14	3006962	protein homolog model	n/a	n/a	carbapenem; cephalosporin	antibiotic inactivation	ORN beta-lactamase	GCCAGCGGCGTCTCCGTGGTGACCACCATCGACAAGCAGGACCAGCCACGGGGACTGACCTGCTCGGCGATCTGCAGTGTCTCCCTGGACCCGCCGCTGCTGCTGTCCAGTGTCAGCAACCACAGCGGCACCCTCGAGTCGATCCTGACCACCGGCAAGTTCGCGGTGAACATCCTCGGCTCCCAGGGCCAGGCCGTGTCCCAGTTGTTCGCCTCGGGTGCGGAGGACAAGTTCGAGCGGGTGAGCTGGGAGCCGGGCCCGATGACCGGCAGCCCGGTGTTGCAGGTGACCGTGGCCCACGCGGAGTGCGAGCTGTACAACGCCGTGGAGGCCGGTGACCACACACTGCTGATCGGCCGCCTGGTCAGCGGCAGCACCGAGCAGGACCGGATGCCGTTGGCCTACTGGCGCGGCTCCTACGGCCGGCTCGACCAGGAGACCGCGCCGCGGGCGTCCTGA	ASGVSVVTTIDKQDQPRGLTCSAICSVSLDPPLLLSSVSNHSGTLESILTTGKFAVNILGSQGQAVSQLFASGAEDKFERVSWEPGPMTGSPVLQVTVAHAECELYNAVEAGDHTLLIGRLVSGSTEQDRMPLAYWRGSYGRLDQETAPRAS	MRQYRFALLPLLAALALPGWAHEATVTTVKQAESQLQGRVGYAELDLASGQLLSGYRAGERFPMMSTFKVLLCGAVLSRVDTGEEQLDRRIHYRQQDLVEYSPVTEKHLADGLTVGELCAAAITLSDNTAANLLLTTLGGPQGLTTFLRHSGDQTSRLDRWETELNEARPGDVRDTTTPEAMARILRNLLTGRVLSPASQQQLQRWMVEDKVAGPLLRSALPAGWFIADKTGAGNRGSRGIIAALGPDGKAARIVVIYLTATPASMDERNKQIAAIGETLVRHWSKDDKRP	52.23	gnl|BL_ORD_ID|3730|hsp_num:0	4800			81	192	
BGC0000130.1|Pyrrolomycin_2 # 534 # 833 # -1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=AGGAGA;rbs_spacer=4bp;gc_cont=0.677	BGC0000130.1|Pyrrolomycin_2 	534	833	-	Loose	950	26.5646	msrE	70.59	3003109	protein homolog model	n/a	n/a	macrolide antibiotic; streptogramin antibiotic	antibiotic target protection	msr-type ABC-F protein	ATGCTTGAACTGGCGGTCACCCAGCGGGTGATCCTGGACTGGCTGGTGGAGCAGGTCGCCGAGCGACTCGGAATACCCCCGGAAGAGGTCCCCGTGGACGCGTACATCGACGAGTTGGAGATCGACTCGGCCGACGCCGTGGGGCTCGTCACCGACCTGGAACGCTGGTTCGGCTACCAGCTCGACGTCAAGGCCGTGTGGCGCTACCCCACGATCCTGGCGCTCTCCGGGTACCTGGCCCGGGAGTACGCCCGCGGCGGTCCGGGTGCACGGATGAAGCGGAACGACTCCCTGCTGTAG	MLELAVTQRVILDWLVEQVAERLGIPPEEVPVDAYIDELEIDSADAVGLVTDLERWFGYQLDVKAVWRYPTILALSGYLAREYARGGPGARMKRNDSLL	MSLIIKARNIRLDYAGRDVLDIDELEIHSYDRIGLVGDNGAGKSSLLKVLNGEIVLAEATLQRFGDFAHISQLGGIEIETVEDRAMLSRLGVSNVQNDTMSGGEETRAKIAAAFSQQVHGILADEPTSHLDLNGIDLLIGQLKAFDGALLVISHDRYFLDMVVDKIWELKDGKITEYWGGYSDYLRQKEEERQHQAVEYELMMKERERLESAVQEKRQQANRLDNKKKGEKSKNSTESAGRLGHAKMTGTKQRKLYQAAKSMEKRLAALEDIQAPEHLRSIRFRQSSALELHNKFPITADGLSLKFGSRTIFDDANFIIPLGAKVAITGSNGTGKTSLLKMISERADGLTISPKAEIGYFTQTGYKFNTHKSVLSFMQEECEYTVAEIRAVLASMGIGANDIQKNLSDLSGGEIIKLLLSKMLLGKYNILLMDEPGNYLDLKSIAALETMMKSYAGTIIFVSHDKQLVDNIADIIYEIKDHKIIKTFERDC	20.16	gnl|BL_ORD_ID|27|hsp_num:0	33			63	114	erythromycin
BGC0000130.1|Pyrrolomycin_3 # 995 # 2668 # -1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=11bp;gc_cont=0.716	BGC0000130.1|Pyrrolomycin_3 	995	2668	-	Loose	350	30.0314	vanI	35.59	3003723	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; Van ligase	ATGAAAGCCATCAAGTCCCCCGAGCACGACCGGCGGCTCGCCAGGGCGGCCGACCCCGCCGAGAAGTACGACGTCGCGATACTCGGCGGCTCCATGGCCGCCGGGCTGCTGGGAGCGGTGCTGTCCCGGCAGGGAGTGCGGGTGCTGTTGGTCGGCGCGGCCGACGACGACAGTGACCCCGCCGGGGAGACCACGGTCCCCTACACGGCCGAGGTCTTCCTCCTGTTGGCCAAGCGCTTCCAGGTGCCGGAGATCGCGGCCTTCGGGTTGTTCACCGACCTCCCGCCCTGGGTCAGGAGCGAGAGCGGGGTCAAGAAGAGCCTGGGCTTCCTCTACCACCACCCGGGACGTCCCCAGGACCCCCACGAGTGCGTCCAGTTCAACGTCCCCAACGAGCACGGCGAATGGCACCTGTACCGGCGGGGCGTGGACCGTTACACCCGGGAGCTGGCCGCGAAGTACGGGGCCGCGCTCGCCGGTGCGGACGTGTTCGTCTCCGACGCCTGGGTGGAGGAGGACGAGGGCCGGGTGCGGGTCAGCGACGGCACCGTCTACCGGGCCCGGTTCCTGGTGGACTGCGTCGGTCCCGACTCGCCGCTGCTGGTGCGCAACGGGGGGGACGACGCCGAGCCCCGGCTGCGGCACACCTCGCGGGTCTACGCCACCCAGATGCGGGGGGTCGTCCCGTTCGAGGCCCTGGTGCCGCCGAGCCGCCAGGACAAGGTCACCCCGTGGTCCGAGGGCACGGTGCACCACCTGTTCGACGGCGGCTGGGTCCAGTTGGTGGACTTCGGCAACCACAAGGAGAGCCGCAACCCGACCACCAGCGTCACCCTCAGCGTCGACCCGGAGCGCTTCCCCGACCTGCCCGAGGAGCCGGACAAGGCCTTCCGCCAGGTGGTGGAGAGGTTCCCGGACCTCGCCAGGCAGTTCGAGAACGCCACGCCGGTGCGTCCCTGGACCGTGGAGACCCGCTACCAGCGCACCGCGAGCACCACCCACGGCGAGCGTTGGTTCGGCCTGGAGCGCACGGCCGCCCGCAACGACATGTTCCTGGCCCGGGACGCGACCATGGCCGCCGAGTCGGTGCACGCCCTGGCCTCGGTGCTGATCCCCGCGGTGCGCCGGGACAACTGGTCGCCCGCTCCGTTCGCGCGCGTGGCCCTGTTCCAGGAAGCCCTCGGCGAGTTCAACGACCGGCTGCTGCACGCCGCCAGGACCGCCTGCCAGGACTTCCGGCTGTGGAACGCCTTCTCCCGGGTGTGGCTGCTGTGGCAGATCCTGGCCGACCTGTCGCTGAAGCGGGCCCGGCTGGACGCCGAGTCCAGCGGGGACTGGTCGGTGTGCGAGCAGTACGAACTGGGCGGGATCTGGTTCCAGTGCCCGCGGGGCCTGCGGGAGCTGATCGACCGCAGCCTGGAGACCGTGGACGAGGTGCGCCGCGGGGGACTGGCGGCCGGGGCCGCGGCGGACCGCATCTTCGCGGAACTGCGCCGGGAGCCGTTCGTGCCGCCGCTGTACGCGTTCGGGGACCCGGGCGCCCGCGTGTACCGGTTCACCCTGCCCAAGCGGTTGCAGATGCTGTTCTGGGTGAAGACCAAGGCTCCCGCGGACTTCCGCAGGCTGCTGACGGTGGACAACGTCAGCGGGGTGACGGCTGCCTCGAGCCGCTGA	MKAIKSPEHDRRLARAADPAEKYDVAILGGSMAAGLLGAVLSRQGVRVLLVGAADDDSDPAGETTVPYTAEVFLLLAKRFQVPEIAAFGLFTDLPPWVRSESGVKKSLGFLYHHPGRPQDPHECVQFNVPNEHGEWHLYRRGVDRYTRELAAKYGAALAGADVFVSDAWVEEDEGRVRVSDGTVYRARFLVDCVGPDSPLLVRNGGDDAEPRLRHTSRVYATQMRGVVPFEALVPPSRQDKVTPWSEGTVHHLFDGGWVQLVDFGNHKESRNPTTSVTLSVDPERFPDLPEEPDKAFRQVVERFPDLARQFENATPVRPWTVETRYQRTASTTHGERWFGLERTAARNDMFLARDATMAAESVHALASVLIPAVRRDNWSPAPFARVALFQEALGEFNDRLLHAARTACQDFRLWNAFSRVWLLWQILADLSLKRARLDAESSGDWSVCEQYELGGIWFQCPRGLRELIDRSLETVDEVRRGGLAAGAAADRIFAELRREPFVPPLYAFGDPGARVYRFTLPKRLQMLFWVKTKAPADFRRLLTVDNVSGVTAASSR	MTKLKIAIIFGGCSEEHPVSVKSAGEVAKNLDPEKYEPFYIGITKDGVWQLCHYPEVNWEKGSCRPAILSPDRSVQGLLVLEQGQYQRIPLDLVFPVLHGKFGEDGAMQGLLELSGIPYVGCDIPSSALCMDKSLAYIVAGKAGIATPKFRTVTVKETIDAERLTYPVYVKPARSGSSFGVTKVCRQEELLNAVEIASQYDSKVLIEETVIGTEIGCAIFGNDLDLIAGEVDQIRLSHGFFRIHQENEPEKGSENSTLIVPAGISAEARSRVQETAKAIYRALGCRGLARVDMFLKEDGTVILNEVNTLPGMTSYSRFPRMMAAAGLPFAEVIDRLVSLALKGKTGTN	160.06	gnl|BL_ORD_ID|2043|hsp_num:0	2241			759	927	vancomycin; teicoplanin
BGC0000130.1|Pyrrolomycin_4 # 2841 # 3485 # -1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=GGGAGG;rbs_spacer=10bp;gc_cont=0.752	BGC0000130.1|Pyrrolomycin_4 	2841	3485	-	Loose	400	30.8018	vanR gene in vanF cluster	30.65	3002925	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanR	ATGGACCAGATCGTCGACCGTCTGCTGGCCCTACCGGCGTGGCTCACCCTGATCCTGGTCTTCCTGCTGCCCGCGCTCGAGGCGGCAGCGTTCCCCGGCGTCCTGCTGCCCAGCCAGTCCGCGGTGATGGCCGGCGGAGTCCTCGCCTACCACGGCAGCGCGCCGATCGGCGCGGTGCTGGTCGCCGCCGTGCTCGGTGCGGTGGTCGGGCCGGGGGTCGGCTACCTGGTCGGCCAGCGGTGCGGGGCGCTGATGGTCGCGCGGGTACCCGAGTGGCTGGTCAAGTCCGCGGACCTGGCCAGGGCCGAGGACCTGCTGCGCCGCCTCGGTGGCGCCGCCGTGGTCGCTGCCCGTTTCTTCGTCGGCCTGCGCACCGTGGTTCCGGTGCTCAGCGGCACCGCCCGACTGCCCTACCGACGGTTCCTGGCCTGGAACGCCCTCGCCGGCACGATATGGGGCGTGGGCTGGGGACTGGCGGGATTCGCCGCGGGGGACACCTGGCAGCGGATCGGGGAGTCCACCGGGCAGGTGGCGGGAGCGCTGTTGGCGCTGGCGCTGGTGGCGCTGCTGGTCCGTGCGCTGGTGCGGCGGCGGCTGGACGACCACGCCGGGCCCTCCGCCCACCAGCCGCCCGCCCCGCACTGA	MDQIVDRLLALPAWLTLILVFLLPALEAAAFPGVLLPSQSAVMAGGVLAYHGSAPIGAVLVAAVLGAVVGPGVGYLVGQRCGALMVARVPEWLVKSADLARAEDLLRRLGGAAVVAARFFVGLRTVVPVLSGTARLPYRRFLAWNALAGTIWGVGWGLAGFAAGDTWQRIGESTGQVAGALLALALVALLVRALVRRRLDDHAGPSAHQPPAPH	MKNITILIADDDAEIADLVAIHLEKEGYRVIKVSDGQETIDVIQNQPIDLLILDIMMPKMDGFEVTRRIREKHNMPIIFLSAKTSDFDKVQGLVIGADDYMTKPFIPIELVARVNAQLRRFMKLNQPKTKQNSNLEFGGLTISPEQRTVTLYGKNIELTPKEFEILFLLASNPNKVYRAEDIFQKVWGDAYYEGGNTVMVHIRTLRKKLEEDKRKNKLIQTVWGVGYKFNG	92.64	gnl|BL_ORD_ID|298|hsp_num:0	240			531	693	vancomycin
BGC0000130.1|Pyrrolomycin_5 # 3969 # 4937 # -1 # ID=1_5;partial=00;start_type=TTG;rbs_motif=AGGAG;rbs_spacer=7bp;gc_cont=0.682	BGC0000130.1|Pyrrolomycin_5 	3969	4937	-	Loose	500	39.6614	Mycobacterium tuberculosis inhA mutations conferring resistance to isoniazid	26.35	3003393	protein variant model	S94A	n/a	isoniazid-like antibiotic	antibiotic target alteration	isoniazid resistant inhA	TTGAAGAACTCGACCCCTGCCACCGGCGCGGTCGTCGTCACCGGGACATCCACCGGCATAGGACGCGCCGTCGCGCTTCGGCTCGCGGCGAACGGCTACCAGGTCTTCGCCGGAGTCCGAAAGGAGTCCGACGGCGCAGAACTGCGCAATGCGGCTCGTGGCTCCATCGAACCGCTCATCCTGGACGTGACCAACAGCGACCACATCAAGGCAGCAGCGCAACGGGTCCTCGAGGCCACCGACGGACGCGGCGCCGTCGGTCTGGTGAACAACGCCGGCGTCGGCATCACCTCGCCGACCGAGATCGTCCCCATGGCCACCATCCGGAGAAGCTTCGAGATCAACTTCTTCGGTCAGCTCGAGATGATCCAGGAGTTCCTGCCGCAACTCCGGCAGACCAGGGGACGCCTGATCAACATCGGGTCCATCGGCAACCGCGTGGTGATGCCCTTCGCCGGCCCGCTCAACGCGTCCAAGTGGGCGCTGGCCGCGATCAACCACGCCCTGCGGGTGGAACTGCTCCCGTGGGGCATCCACGTGGTGCTGATCGAGCCGGCGTCGATCAAGACCGCGGCCGTGGACAAGCTGGAGCAGGACGGCCTCGACAACATCACCCAGTTCAGCGACCACGAGCGGTTCCTCTACGAGGACGCCTACCGCTCCATGCTGGGCAACGCCACGATGCACGTCCGCCGGCTCGGCACCTCGTCCGAGGCCGTGGCCAAGGCGGTGCACCGGTCGATGGTCTCGCCCCGGCCCAAGGCCCGCTACCTGGTGGGCAAGTCCGCCCGACCGCTCGCCGCGGTGGTGAAGTACGCCCCCGACCGCCTGTACGACAAGGTGCGGCTCAAGGTGTTCGCCCTGCCCAAGTCCTTCGGCGCCCGCGCCGGGGAGGCCCAGCCCCACCTGATGCCGCAGGGGACCAACCAGCCCAAGGTCGCCACCGACGGTCGCCGCAAGGCCGCCTGA	MKNSTPATGAVVVTGTSTGIGRAVALRLAANGYQVFAGVRKESDGAELRNAARGSIEPLILDVTNSDHIKAAAQRVLEATDGRGAVGLVNNAGVGITSPTEIVPMATIRRSFEINFFGQLEMIQEFLPQLRQTRGRLINIGSIGNRVVMPFAGPLNASKWALAAINHALRVELLPWGIHVVLIEPASIKTAAVDKLEQDGLDNITQFSDHERFLYEDAYRSMLGNATMHVRRLGTSSEAVAKAVHRSMVSPRPKARYLVGKSARPLAAVVKYAPDRLYDKVRLKVFALPKSFGARAGEAQPHLMPQGTNQPKVATDGRRKAA	MTGLLDGKRILVSGIITDSSIAFHIARVAQEQGAQLVLTGFDRLRLIQRITDRLPAKAPLLELDVQNEEHLASLAGRVTEAIGAGNKLDGVVHSIGFMPQTGMGINPFFDAPYADVSKGIHISAYSYASMAKALLPIMNPGGSIVGMDFDPSRAMPAYNWMTVAKSALESVNRFVAREAGKYGVRSNLVAAGPIRTLAMSAIVGGALGEEAGAQIQLLEEGWDQRAPIGWNMKDATPVAKTVCALLSDWLPATTGDIIYADGGAHTQLL	119.70	gnl|BL_ORD_ID|1964|hsp_num:0	1574			174	606	isoniazid
BGC0000130.1|Pyrrolomycin_6 # 5229 # 5738 # -1 # ID=1_6;partial=00;start_type=GTG;rbs_motif=AGGG;rbs_spacer=8bp;gc_cont=0.667	BGC0000130.1|Pyrrolomycin_6 	5229	5738	-	Loose	400	26.1794	ErmV	28.71	3002824	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	GTGCGGGTGTGGCGACACTTCAGGGCGGTTCTGCTCGCGCCGGTGCTGATGGCCGTGGTGGTGCCGTTGGCGATCTGGCTCACCGCGGGACTCCGGCAGGTGGAGGTTCCGGCGGCGGGGCGCTGGTTGGCCCTGGCGGTGGGCGGTGCCCTGGTTTCCGCCGGGGTGGCCCTCTTCCTGTGGACCAACGTCCTCTTCGACCGCGAGGGCAAGGGCACTTTGGCGATCTTCGATCCGCCGCGGCGGCTCGTGGTGCGGGGGCCGTACCGTCACGTGCGCAACCCCATGATCACTTCGGTGATCGCCGTGCTGTTCGGCGAGGCCGTGATGACCCGGTCGTCGTGGTTGATGTTGTGGAGTCTGACGTTCCTCGGGGTCAACATGCTCTTCATGCCGCTGTTTGAGGAGCCCGGACTGGTCCGCCGTTTTGGTGAGGATTACATGCGATACCGAGCGAATGTTCCGCGATGGCTGCCCCGAGTTCGGCCGTGGTCGGGGCCAAGTGACTGA	MRVWRHFRAVLLAPVLMAVVVPLAIWLTAGLRQVEVPAAGRWLALAVGGALVSAGVALFLWTNVLFDREGKGTLAIFDPPRRLVVRGPYRHVRNPMITSVIAVLFGEAVMTRSSWLMLWSLTFLGVNMLFMPLFEEPGLVRRFGEDYMRYRANVPRWLPRVRPWSGPSD	MARPSRVSRALSQNFLADRAAAGQLARLAAPHGLPVPLLLEVGAGKGALTELLAPRCRSLLAYEIDPRLVPVLRSRFADAPHVRVLGEDFLRARAPRTPFSVAGNVPFSRTAAVVAWCLRAPHLTDATLLTQLEYARRRTGDYGSWTRLTVLTWPRHEWRLAGRVGRRSFRPVPRVDAGIVRIERRRTPLLAPGADAGWRELVDLGFSGAGGSLHASLRRARPRRRVDAAFRAAGLDRDVLVGEVPPWTWLRLHEVLGS	65.25	gnl|BL_ORD_ID|1095|hsp_num:0	1188			18	285	erythromycin; tylosin; oleandomycin; chalcomycin; kitasamycin; carbomycin; celesticetin
BGC0000130.1|Pyrrolomycin_7 # 6399 # 7340 # 1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=8bp;gc_cont=0.711	BGC0000130.1|Pyrrolomycin_7 	6399	7340	+	Loose	850	25.409	hp1181	32.31	3003964	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; tetracycline antibiotic; nitroimidazole antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGCGCCCATCAGCGCCCGACCAGGGCAGTGTCGTCATCACCGGGGCGTCGACCGGCATCGGCCGCGCCTGCGCCCTGCACCTCGCGGAGAACGGGTTCCAGGTGTTCGCCGGCGTCCGCAAGGAGGCCGACGGCGCGTCCCTCGAGCGTGACGCCAAGGGGAGCCTGCGCGCGCTGCTCCTGGACGTGACCGACCAGGAGCAGATCGAGGCCGCGGCGGCCGAGGTCTCCCGGAGCAGCGGCGGGAAGCTGCGCTGCCTGGTGAACAACGCCGGGATCGGCATCCCCGCCCCGACCGAACTGGTGGACCTGGACCTGCTCCGCAGGCAGTTCGAGGTCAATGTCTTCGGACAGGTCGCGGTCACCCAGGAGTTCCTGCCGCTGCTGCGGGCGGCGACCGGCCGCATCGTCAACATGGGTTCGATCGCGGACCGGTTGACGATGCCGTTCGCCGGTCCGTTGAACTCCTCGAAGCACGCCCTGGCGTCGCTCAACGACGCGCTCCGCTTCGAGCTGCGCCCCTGGGGCATCCACGTGGTGCTCATCGAGCCCGCCGCCATCCGCAGTGCCGCGGCGGACGGCGTGAAGGAGCACGGGCAACGGCTCGTCGACGGACTGAGCCCCCGCGGTCGCCACCTCTACGAGGACGCGCTGCGCTCGATGCTGTCAGCGATGAGCGACAAGATGGGCAGGATCGCCGCTCCGCCGTCCACGGTCGCCAAGGTGGTGCACCGGGCGATCACCGTCGACCGACCCAAGACCCGTTACCTGGTCGGCAAGCCGGCGCGTCCACTGGCCGCCATCTCCAAGGTGGCCTCGGACCGGGCCTTCGACATGATCAAGGCCCGGATCTTCGACCAGCCGCGCGGCTTCGGGAGCCGGGGCGCCGACGTACCGGACGACCTGGAGTCGGTCCGGCGGGCGAGGCGGCGGGCGTCCTGA	MRPSAPDQGSVVITGASTGIGRACALHLAENGFQVFAGVRKEADGASLERDAKGSLRALLLDVTDQEQIEAAAAEVSRSSGGKLRCLVNNAGIGIPAPTELVDLDLLRRQFEVNVFGQVAVTQEFLPLLRAATGRIVNMGSIADRLTMPFAGPLNSSKHALASLNDALRFELRPWGIHVVLIEPAAIRSAAADGVKEHGQRLVDGLSPRGRHLYEDALRSMLSAMSDKMGRIAAPPSTVAKVVHRAITVDRPKTRYLVGKPARPLAAISKVASDRAFDMIKARIFDQPRGFGSRGADVPDDLESVRRARRRAS	MFKKIFPLALVSSLRFLGLFIVLPVISLYADSFHSSSPLLVGLAVGGAYLTQIVFQTPMGILSDKIGRKVVVMVCLLLFLAGSLVCFIANDIVWLVIGRFIQGMGALGGVISAMVADEVKEEERTKAMAIMGAFIFISFTISMAIGPGVVAFLGGAKWLFLLTAILTLLSLLMLLKVKDAPKISYQIKNIKAYQPNSKALYLLYLSSFFEKAFMTLIFVLIPLALVNEFHKDESFLILVYVPGALLGVLSMGIASVMAEKYNKPKGVMLSGVLLFIVSYLCLFLADSSFLGKYLWLFIVGVAFFFIGFATLEPIMQSLASKFAKVHEKGKVLGQFTTFGYLGSFVGGVSGGLSYHHLGVSNTSLIVVALGLIWGLSLFLLNNPSKQKNVYFPLDAYNEEQFETLEDKIIEWYVNISEEIIIVKYNSDHISEEEIIHLAQNFRK	70.65	gnl|BL_ORD_ID|2191|hsp_num:0	2430			24	204	ciprofloxacin; tetracycline; metronidazole
BGC0000130.1|Pyrrolomycin_8 # 7679 # 7873 # -1 # ID=1_8;partial=00;start_type=TTG;rbs_motif=AGGA;rbs_spacer=8bp;gc_cont=0.672	BGC0000130.1|Pyrrolomycin_8 	7679	7873	-	Loose	1000	22.7126	MCR-2.2	26.67	3004502	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	MCR phosphoethanolamine transferase	TTGGCACCGTTGCGGGACAGCACCGCGGCCATCGCCGCTCCGGCGAGCCCGGAGCCGAGGATCACCACATCGGTGTCTGGGCGCTCGATCTTGGTCGACTTTGTGGTCCTGGTGCTCCTGGGCATGCAGAATCCTCCGAATCACTGGCGGGCGGACGGCATGGGGCCGCACAGCCTGCCGCGTTCATGGGCTTGA	MAPLRDSTAAIAAPASPEPRITTSVSGRSILVDFVVLVLLGMQNPPNHWRADGMGPHSLPRSWA	MTSQHSWYRYSINPFVLMGLVALFLAATANLTFFEKAMAVYPVSDNLGFIISMAVALMGAMLLIVVLLSYRYVLKPVLILLLIMGAVTSYFTDTYGTVYDTTMLQNAMQTDQAESKDLMNLAFFVRIIGLGVLPSVLVAFAKVNYPTWGKGLIQRAMTWGVSLVLLLVPIGLFSSQYASFFRVHKPVRFYINPITPIYSVGKLASIEYKKATAPTDTIYHAKDAVQTTKPSERKPRLVVFVVGETARADHVQFNGYGRETFPQLAKVDGLANFSQVTSCGTSTAYSVPCMFSYLGQDDYDVDTAKYQENVLDTLDRLGVDILWRDNNSDSKGVMDKLPTTQYFDYKSATNNTICNTNPFNECRDVGMLVGLDDYVSANNGKDMLIMLHQMGNHGPAYFKRYDEQFAKFTPVCEGNELAKCEHQSLINAYDNALLATDDFIAKSIDWLKTHEANYDVAMLYVSDHGESLGENGVYLHGMPNAFAPKEQRAVPAFFWSNNTTFKPTASDTVLTHDAITPTLLKLFDVTADKVKDRTAFIQ	11.90	gnl|BL_ORD_ID|2665|hsp_num:0	3130			687	822	colistin A; colistin B
BGC0000130.1|Pyrrolomycin_9 # 7944 # 9503 # 1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.660	BGC0000130.1|Pyrrolomycin_9 	7944	9503	+	Loose	1300	28.4906	optrA	27.47	3003746	protein homolog model	n/a	n/a	oxazolidinone antibiotic; phenicol antibiotic	antibiotic target protection	Miscellaneous ABC-F subfamily ATP-binding cassette ribosomal protection proteins	ATGCTCATGCGTCTGGTCAGTGAGCGGTATGACGTTCCCGAGATCAAGTACCTCACCACGTTCGAGAACGTGCAGGGAAAGATCACCAGTACCTGCGGCATCAAGAAGAACTTCGGGTTCCTCTACCACCGCGAGGGCGAGCGCCAGAAGTACCACGAGGCGCACCAGTTCCCGATCCCGCGGATCACGCACATCGAGAACCACTTCTTCCGCCAGGACATCGATGCCTGGATGCTCAATGTCGCGGTGAAGTACGGCGCCCGTATCCAACAGCGCACCCGCATCGTGGACGTGGCGTTCGACGACGCCGGTGGCACCCTCACCGATGACCAGGGCAGGACCTACCGGACCCGGTTCGTGGTGGACGCGAGCGGCTTCAGGTCCCCCCTGGCCGAGAAGCTCGACCTGCGTGACCAGCCCACCCGGATGCGGCACCACTCGCGCTCGATCTTCACCCACATGGTGGGCGTGCCGGACTACGACGACCTGCTGCCGAAGGTCTCCCACGGTCACCCCACCCGGTGGGCCCAGGGCACCCTGCACCACATCTACGAGGGCGGCTGGGGCTGGGTCATCCCGTTCAACAACCACGCCCGGGCGACCAACCCGCTGGTCAGCGTCGGGTTCAGCTTCGACCCGCGGATCCACCCGGACTTCGACGGCACCCCGGAGGAGGAGTTCCGGGCCTTCATCGACCGTTTCCCCGACATCCGGCGCCAGTTCGTCGACGCCACCGCGGTCCGCCCCTGGGTGCGCACCGGCCGGTTGCAGTACTCCTCGAGCAAGACCGTCGGTGCCCGCTGGTGCCTGACCTCGCACGCGGCCGGCTTCGTGGACGCGCTGTTCTCCCGGGGCCTGTCCAACTCCTTCGAGATCATCAACGCGCTGACCTGGCGGCTGCTCGAGGCTCTGCGCGACGACGACTTCACCGAGGAGCGCTTCGAGTACGTCCAGCGGCTCGAGCAGGGCCTGCTGGACTTCAACGACAACCTGGTGGCGAACGCGTACACGTCGTTCGGCCACTACGACCTGTGGGACACCTGGTTCCGGGTCTGGTCTCTGGGGCAGATCCTGGCCACCTTCGAGATCAACTCCACCTACGCGAAGTTCCTGGAGTCCCACGACGTGCGGGACCTCACCCGGCTGGAGGGGATCGCCCCCGACGGGTCCATCCCGAGCTACGCACCCGCCCGCGAGCTGATGAACTTCGTCAGCGACCAGGTGAGCCAGGTGCAGGAGAAGCGCAACGACGCGGGGGTGGCCGCCAAGGCCATCATGGAGGCGTTGCAGAAGGCGGACTTCGTGCCGCCGGCGTTCGGCCTGGCCGACGCGGACAACCGCTGGTTCAACGCGAGCACCAAGAAGGTCATGGAGACCATCAAGTGGGCCCGCAACTCCGCACCCAGGGAGATCGGGACGCTGGTGGACGAGGGCCTGACCCTGTTCATCAAGAAGCGGCTGTCCCGCGACGAGTTCGACCTCGCCGAGGAGGCCAAGCACATCGTGGCCGCCTGGCCCGTGATCGGTAGGAAGTTCCGTTCCCCGTCGCTGTCGTACTGA	MLMRLVSERYDVPEIKYLTTFENVQGKITSTCGIKKNFGFLYHREGERQKYHEAHQFPIPRITHIENHFFRQDIDAWMLNVAVKYGARIQQRTRIVDVAFDDAGGTLTDDQGRTYRTRFVVDASGFRSPLAEKLDLRDQPTRMRHHSRSIFTHMVGVPDYDDLLPKVSHGHPTRWAQGTLHHIYEGGWGWVIPFNNHARATNPLVSVGFSFDPRIHPDFDGTPEEEFRAFIDRFPDIRRQFVDATAVRPWVRTGRLQYSSSKTVGARWCLTSHAAGFVDALFSRGLSNSFEIINALTWRLLEALRDDDFTEERFEYVQRLEQGLLDFNDNLVANAYTSFGHYDLWDTWFRVWSLGQILATFEINSTYAKFLESHDVRDLTRLEGIAPDGSIPSYAPARELMNFVSDQVSQVQEKRNDAGVAAKAIMEALQKADFVPPAFGLADADNRWFNASTKKVMETIKWARNSAPREIGTLVDEGLTLFIKKRLSRDEFDLAEEAKHIVAAWPVIGRKFRSPSLSY	MSKATFAIASTNAKEDMKMQYKIINGAVYYDGNMVLENIGIEINDNEKIAIVGRNGCGKTTLLKAIIGEIELEEGTGESEFQVIKTGNPYISYLRQMPFEDESISMVDEVRTVFKTLIDMENKMKQLIDKMENQYDDKIINEYSDISERYMALGGLTYQKEYETMIRSMGFTEADYKKPISEFSGGQRTKIAFIKILLTKPDILLLDEPTNHLDIETIQWLESYLRSYKSTLVIISHDRMFLNRIVDKVYEIEWGETKCYKGNYSAFEEQKRENHIKQQKDYDLQQIEIERITRLIERFRYKPTKAKMVQSKIKLLQRMQILNAPDQYDTKTYMSKFQPRISSSRQVLSASELVIGYDTPLAKVNFNLERGQKLGIVGSNGIGKSTLLKTLMGGVAALSGDFKFGYNVEISYFDQQLAQISGDDTLFEIFQSEYPELNDTEVRTALGSFQFSGDDVFRPVSSLSGGEKVRLTLCKLLYKRTNVLILDEPTNHMDIIGKENLENILCSYQGTIIFVSHDRYFTNKIADRLLVFDKDGVEFVQSTYGEYEKKRMNSEKPFNNIKVEQKVEKNNTVKGDRNSIEKEKVKKEKRIEKLEVLINQYDEELERLNKIISEPNNSSDYIVLTEIQKSIDDVKRCQGNYFNEWEQLMRELEVM	79.24	gnl|BL_ORD_ID|2069|hsp_num:0	2263			828	1089	linezolid; chloramphenicol; florfenicol; tedizolid
BGC0000130.1|Pyrrolomycin_10 # 9537 # 11195 # 1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=7bp;gc_cont=0.667	BGC0000130.1|Pyrrolomycin_10 	9537	11195	+	Loose	550	32.3426	Nocardia farcinica rox	33.33	3007210	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	ATGATCTCGAAGGCCAACAGGTTCGACGTCGCCATCATAGGCGCCGGCATGGGCGGCTCGATGCTGGGCGCCGCTCTCGCCCGCAACGGCGTCAAGGTCCTGCTGATAGACGGCGGCATACACCCCCGGTTCGCCGTTGGTGAGGCGACGATCCCCTACACCAACGTCTCCCAGCGCATCATCGCCGCGCGGTACAACCTCCCCGAGCTGACCACCCTGTGCACCCTCGAGGACTGCACCAAGGCGATCGGCCCGACGTTCGGCACCAAGACCCACTTCGGCTTCCTGCGGCACGAGCAGGGCAAGCCGCAGAACCCGCGGGAGACCAACGAGTTCCACACCCCCGGGCTGCTGCACGAGGCCCACCACCTGTACCGGCAGGACGTGGACGCCTTCGTGTTCCACCTGGCGGTGCGCTGCGGGTGCACCCCGCTGCAGAACTGGCGCGTCGCCGACGTGGACTTCGACGGGTCGGGCGCGAGCCTGCACGGCGAGGACGGCTCGGAGTACCGGGCGCGCTACGTGGTGGACGCCAGTGGCTACCGTTCGCCCCTGGCGAAGAAGTTCAACCTGCGCGACGAGATCCCCAAGTACAAGCACCACTCGCGGTCGATGTTCACCCACGTCGCCGGGATCACGCACACCGACGACCTGTGGCCGGACCGCAAGCCGGAGTACGTGCCGCCGGTTCCGTGGTACGAGGGCACCGTCCACCACATGTTCAACCGTGGTTGGGGGTGGGTCATCGGGTTCGACAACACCCCGCTGTCCCGGAACCCGCTGTGCTCCATCGGTCTGACCGTGGACCCGCGGGTGTGGCCCAAGGACCCCAGCCTCTCCGTCCAGGAGGACTTCGACCGGATCACCGGGCTCTTCCCGGACATCAAGCGGCAGTACGCCGGGGTCACCCCGGTCCGCGAATGGGTTTCCACGGACCGCCTCCAGTACTCCTCGAAGCAGACCGTCGGTGACCGCTGGTGCCTGCTGTCGCACGCCGCGGCCTTTATCGACCCGCTGTTCTCGTACGGTCTGGCCAACACCGGCGACGCGGTGAACAAGCTGGCCTGGCGGCTCATCCGGGCCTGCAAGGACGACGACTTCTCCGCGGAGCGCTTCGACCACATCGAGCAGTGGCAGCAGGCCCGCTTCCACTACAACGACGAGATCGTCAACTCCGGTTTCACCGCGTTCGACCACTTCGAGCTCTGGAAGGCCGTCTTCCGGGTCTGGGTGTGGGGCAACAACTACGGCACCTTCCGGGCGCGGGCCGGGCTGACCAAGTTCGAGCAGGACGGCAACGACCAGCACCTGCGGGACCTGGAGAAGGGCCAGTACCTGGGTTACGACTGGCCGGACCACGAGGGCTTCAAGCACCTGTTCGACACCATGGTGCGGAACATCGACGCCTTCGAGGCCGGGAAGATCACCGCGGACGACGCGGCCGAGGAGATGTGGGCGGTGCTGGAGGAGGTCAACTTCATGCCCAAGCCCTTCGGCTTCCAGGACCGCTCGGTGCACTTCATGAGCCCCAAGCCGCCGGTCATCGCCAAGACCGCGGTCTGGCTCGCCCGGCACGGTGACCCCACCGTCCGCAAGATGCTGCTCAAGAGCGGTCGGCAGGCCATCAAGCTCCGGCTGACCAACCGCAAGATCTTCTGA	MISKANRFDVAIIGAGMGGSMLGAALARNGVKVLLIDGGIHPRFAVGEATIPYTNVSQRIIAARYNLPELTTLCTLEDCTKAIGPTFGTKTHFGFLRHEQGKPQNPRETNEFHTPGLLHEAHHLYRQDVDAFVFHLAVRCGCTPLQNWRVADVDFDGSGASLHGEDGSEYRARYVVDASGYRSPLAKKFNLRDEIPKYKHHSRSMFTHVAGITHTDDLWPDRKPEYVPPVPWYEGTVHHMFNRGWGWVIGFDNTPLSRNPLCSIGLTVDPRVWPKDPSLSVQEDFDRITGLFPDIKRQYAGVTPVREWVSTDRLQYSSKQTVGDRWCLLSHAAAFIDPLFSYGLANTGDAVNKLAWRLIRACKDDDFSAERFDHIEQWQQARFHYNDEIVNSGFTAFDHFELWKAVFRVWVWGNNYGTFRARAGLTKFEQDGNDQHLRDLEKGQYLGYDWPDHEGFKHLFDTMVRNIDAFEAGKITADDAAEEMWAVLEEVNFMPKPFGFQDRSVHFMSPKPPVIAKTAVWLARHGDPTVRKMLLKSGRQAIKLRLTNRKIF	MIDVIIAGGGPTGLMLAGELRLHGVRTVVLEKEPTPNQHSRSRGLHARSIEVMDQRGLLERFLAHGEQFRVGGFFAGLAAEWPADLDTAHSYVLAIPQVVTERLLTEHATELGAEIRRGCEVAGLDQDADGVTAELADGTRLRARYLVGCDGGRSTVRRLLGVDFPGEPTRVETLLADVRIDVPVETLTAVVAEVRKTQLRFGAVPAGDGFFRLIVPAQGLSADRAAPTLDELKRCLHATAGTDFGVHSPRWLSRFGDATRLAERYRTGRVLLAGDAAHIHPPTGGQGLNLGIQDAFNLGWKLAAAIGGWAPPDLLDSYHDERHPVAAEVLDNTRAQMTLLSLDPGPRAVRRLMAELVEFPDVNRHLIEKITAIAVRYDLGDGHDLVGRRLRDIPLTEGRLYERMRGGRGLLLDRTGRLSVSGWSDRVDHLADPGAALDVPAALLRPDGHVAWVGEDQDDLLAHLPRWFGAAT	116.70	gnl|BL_ORD_ID|4834|hsp_num:0	5821			345	489	rifampin
BGC0000130.1|Pyrrolomycin_12 # 13668 # 15104 # 1 # ID=1_12;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=3bp;gc_cont=0.763	BGC0000130.1|Pyrrolomycin_12 	13668	15104	+	Loose	800	32.7278	Mycolicibacterium smegmatis ndh with mutation conferring resistance to isoniazid	25.4	3003778	protein variant model	H46P, V246A, V300G	n/a	isoniazid-like antibiotic	antibiotic target alteration	antibiotic resistant ndh	ATGGACACGCAGCAGGTGGTCATCGTCGGCAACGGCATGGCCGGGCACCGGCTCGCCCAGGAGCTGCGCGCCCGGCGCCCGGAGGTGCGGGTCACCCTGGTGGGCGAGGAGCCGCGCCCCGCCTACAACCGGGTGCTGCTGTCCACCGTCCTCGCCGGCACCGTGTCCGCGGACGCCCTGGAGCTCGCCGACTGCGGTGCCCGGATGCGCCTGGGCGTGCGGGCGCTCGAGCTCGACACGGAGCGCCGCCGGGTCACCCTCTCCGACGGGTCGGTCCTCGGCTACGAGACGCTGGTGCTGGCCACGGGGGCGCGCCCGGTGCTGCCCCGGGTGCCGGGGCTCGCCGCCGACGACGGCGGACCCGCGCCCGGGGTGAGCACCTTCCGCACCCTGGCGGACTGCACGCTCATCTCCCGCCTCGCCCTGGGCGGGTCCATGGCCGTGCTCGGGGGCGGGCTGCTCGGGGTGGAGGCGGCCCGGGGCCTGGCCGGGCTGGGGGTGGACGTCACCCTGGTGCACCCGGTGGGTCACCTGATGGAGAACCAGCTCGACCCCGAGGCCGGGGAGGTCCTCGCCCGGATGCTGCGTGACCTGGGCGTGCGGGTGCTGCTCGGCGTGGGTGCCAGCCGTTGGCAGCCGTCGCCGGACGAGGGCGAACTCGTCCTGTCCGACGGCCGGGCGGTGCGGTGCGGCGGGGTCGTGGTGACCGCGGGGGTGGCCCCGGTGACCGAGCTGGCCCGCTCGGCGGGGCTGGCCGTGGGACGGGGCGTCGTGGTGGACGACCGGCTGCGGACCTCCGCGCCCGGGGTGTACGCGATCGGCGAGTGCGCCGAGCACCGGGGTGTGTGCCACGGTCTGGTGGGGCCGTGCTGGGAGCAGGCCGCCGTCCTCGCCGACGTGCTCGTCGGCAAGGACACCGAGTACACCGGGTCCCGTCCGGTGGTGCGGCTCAAGGCCCGCGACGTGGACCTGGCCGCGATGGGTCGTGTCCCCGCGGAGCCGGACGGGGACACCGAGCTGGTGCGGGTGTCCGATGTCACCCGAGGCCGCTACGGCGTTCTCGCGCTGCGCGCCGAACGTCTCGTCGGGGCGATCCTGCTCGGGCTGCCGGACGCCACCGGGCCGGTCACCCAGCTCCATGACTCCGGGTCGCCGGCACCCGCCGACCGCTTCGGGTTGCTGCTCGGGACCGGGGCCGCGGTCAGCGAGACGCCGGACAAGCTGCCGGAACGGGCGCTGGTGTGCCGGTGCAACGGGGTGACCAAGGCCCGGCTCGTCGAGGCCTGGCACGCCGGTGCCCGCGACCCCGAGGCGCTGTCCGTCCTCCACCTGGGCCACCACCGGCTGCGGCAGTTGTTCGGACACCGTGCAGCGGCTGTGCACCTGGCTGGCGCGCGAGGCCGTCTGACCGTCCATGGCCGCCCCGGGCGGCCGTGA	MDTQQVVIVGNGMAGHRLAQELRARRPEVRVTLVGEEPRPAYNRVLLSTVLAGTVSADALELADCGARMRLGVRALELDTERRRVTLSDGSVLGYETLVLATGARPVLPRVPGLAADDGGPAPGVSTFRTLADCTLISRLALGGSMAVLGGGLLGVEAARGLAGLGVDVTLVHPVGHLMENQLDPEAGEVLARMLRDLGVRVLLGVGASRWQPSPDEGELVLSDGRAVRCGGVVVTAGVAPVTELARSAGLAVGRGVVVDDRLRTSAPGVYAIGECAEHRGVCHGLVGPCWEQAAVLADVLVGKDTEYTGSRPVVRLKARDVDLAAMGRVPAEPDGDTELVRVSDVTRGRYGVLALRAERLVGAILLGLPDATGPVTQLHDSGSPAPADRFGLLLGTGAAVSETPDKLPERALVCRCNGVTKARLVEAWHAGARDPEALSVLHLGHHRLRQLFGHRAAAVHLAGARGRLTVHGRPGRP	MSHPGATASDRHKVVIIGSGFGGLTAAKTLKRADVDVKLIARTTHHLFQPLLYQVATGIISEGEIAPATRVILRKQKNAQVLLCDVTHIDLENKTVDSVLLGHTYSTPYDSLIIAAGAGQSYFGNDHFAEFAPGMKSIDDALELRGRILGAFEQAERSSDPVRRAKLLTFTVVGAGPTGVEMAGQIAELADQTLRGSFRHIDPTEARVILLDAAPAVLPPMGEKLGKKARARLEKMGVEVQLGAMVTDVDRNGITVKDSDGTIRRIESACKVWSAGVSASPLGKDLAEQSGVELDRAGRVKVQPDLTLPGHPNVFVVGDMAAVEGVPGVAQGAIQGGRYAAKIIKREVSGTSPKIRTPFEYFDKGSMATVSRFSAVAKVGPVEFAGFFAWLCWLVLHLVYLVGFKTKIVTLLSWGVTFLSTKRGQLTITEQQAYARTRIEELEEIAAAVQDTEKAAS	104.60	gnl|BL_ORD_ID|4710|hsp_num:0	2287			27	1110	isoniazid
BGC0000130.1|Pyrrolomycin_13 # 15412 # 16725 # 1 # ID=1_13;partial=00;start_type=TTG;rbs_motif=GAG;rbs_spacer=5bp;gc_cont=0.677	BGC0000130.1|Pyrrolomycin_13 	15412	16725	+	Loose	700	26.9498	PDC-222	23.13	3006602	protein homolog model	n/a	n/a	monobactam; carbapenem; cephalosporin	antibiotic inactivation	PDC beta-lactamase	TTGGAGCGGTACGCGACCGGGTGTTGGAAGAACGTACCCACGGTTCCAGGAGAACGGAACCTACGGTTCAACACGGTGCCCCACATCCTTCAAGTGATGGTGGAGAAGATGGACCAACACCAAGGCGCGATCTCCTTCCCCTTCCCGGCACGCAGTCACCTCGAGTTCCCCCCGCAGTTCGCGGAGGCACACGCCAAGTGCCCGGTCAGCCGGGTCAAGCTCCCGCACGGCCAGGAGGCGTGGCTGGCCACAGGACACGACGTGGTGCGCAAGGTCCTCGTCGATCCCAACTTCAGTCGGGCCCTCGCAGCCGAGCACGAGAACCGGCGACTCACGCCGGCTGCGATCCTGAACTCCTCCCTGATCGGGCTCGACCCGCCCGACCACACCCGGCTCCGCACCCTGGCCAGCCGCGCCTTCACCGCCCGCAGGGTGGAGCGGCTGCGTCCGCACATCGTCGCCATCATCGACGACCTGCTGACCGCGATGGGGAAGCACGAGGGCCCCGTCGATCTGCTCGAGCACTTCATGCGGCCCCTGCCCGCGCTGGTCATCAGCGAGATGATGGGCGTTCCCGAGCAGGACATCGAGCGGTTCCTGGAGTGGTCCGCCGAGGCCATCGCCGGGCCGAGCAACCCGGAGGCGGCCGCGGCCGGTTACCAGAGCCTGATCGAGTTCTTCGGGAAGCTCATCGAGGACAAGCGGAGGGCCCCCGGGGACGACCTGCTCAGCGCACTGATCGCGGCCCACGACGAACAGGACAAGCTCAGCGACGACGAGATGGTGGCGCTCAGCGTGCTGCTGCTCGTCGCCGGGCACGAGGCCATCACCACGGTCTTCAGTTGGTTCGTCATCATCCTGACCACCCAGTACCCCGAGCACTGGAAGCACCTCCAGAGCCACCCCGAGGACATCGCGCCCACGGTGGAGGAACTGTTGCGGGTGGTTCCCCGAACCAAGATCGGGGGCGGTTTCCCACGGATCGCCAGGGAGGACACCGAGCTGGCGGGGGTGCGGATCAAGGCCGGGGAGGCGGTGATCCCGGCGATGGACGCGGCGAACCGGGACCCGGTGGTCTACGGCGAGGACCCGGAGCGCCTGGACTTCAACCGCTCGGAGAACCCGCACCTCGGGTTCGGCGCGGGGGTGCACTTCTGCATCGGCGCCCCGCTCGCAAGGCTCCAGATGCAGGAGGGCATGCGACTGCTGTTGAAGCACTTCCCCACCCTGCGGGTGGCGGTTCCGGTCGAGGAACTCAAGCTCACCCCGGAGACGGCGATGCGCATCCTGCTGAGCGTCCCGGTGACCTGGTGA	MERYATGCWKNVPTVPGERNLRFNTVPHILQVMVEKMDQHQGAISFPFPARSHLEFPPQFAEAHAKCPVSRVKLPHGQEAWLATGHDVVRKVLVDPNFSRALAAEHENRRLTPAAILNSSLIGLDPPDHTRLRTLASRAFTARRVERLRPHIVAIIDDLLTAMGKHEGPVDLLEHFMRPLPALVISEMMGVPEQDIERFLEWSAEAIAGPSNPEAAAAGYQSLIEFFGKLIEDKRRAPGDDLLSALIAAHDEQDKLSDDEMVALSVLLLVAGHEAITTVFSWFVIILTTQYPEHWKHLQSHPEDIAPTVEELLRVVPRTKIGGGFPRIAREDTELAGVRIKAGEAVIPAMDAANRDPVVYGEDPERLDFNRSENPHLGFGAGVHFCIGAPLARLQMQEGMRLLLKHFPTLRVAVPVEELKLTPETAMRILLSVPVTW	MRDTRFPCLCGIAASTLLFATTPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISLKGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFIATLAGYALTQDKMRLDDRASQHWPALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNPSIGLFGYLAARSLGQPFERLMEQQVFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVGPGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEAYDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRDLGLVILANRNYPNAERVKIAYAILSGLEQQGKVPLKR	110.08	gnl|BL_ORD_ID|4292|hsp_num:0	5362			198	612	
BGC0000130.1|Pyrrolomycin_14 # 17091 # 17405 # 1 # ID=1_14;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=8bp;gc_cont=0.663	BGC0000130.1|Pyrrolomycin_14 	17091	17405	+	Loose	800	23.8682	MuxA	30.3	3004073	protein homolog model	n/a	n/a	macrolide antibiotic; monobactam; tetracycline antibiotic; aminocoumarin antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGACAGCGAACCCCACCGATGTCATCACCCTGGTCAACGTCTACTCGGTCGAGCCGGAGCGTCAGGACGAGCTGGTCGACCTGCTGTACCGCACCGCTGACGAACTGATGCGGCACCAGCCCGGCTTCATCACCGCCCACATCTACCGCAGCATGGACGGCACCCGGGTGACCAACTACGCGCAGTGGCGGTCAATGGCCGACTTCCAGGCCGTGCAGCAGCTCCCCGAGGCGGCGAAGTACGTGAAGGCGTCCGCCGAGCTCGGTGCGTCCGACCCCCACGTCTACACCGTGGCGTCGGTCCACACCGCCTGA	MTANPTDVITLVNVYSVEPERQDELVDLLYRTADELMRHQPGFITAHIYRSMDGTRVTNYAQWRSMADFQAVQQLPEAAKYVKASAELGASDPHVYTVASVHTA	MTPTTGKSKFRTLRPWLITALAFAAVIGLVMWLAAPASAPSSDGRPGRGGKPGAALPKANALTVGVARVEQGDLALHFNALGTVTAFNTVNVKPRVNGELVKVLFQEGQEVKAGDLLAVVDPRTYKAALAQAEGTLMQNQAQLKNAEIDLQRYKGLYAEDSIAKQTLDTQEAQVRQLQGTIRTNQGQVDDARLNLTFTEVRAPISGRLGLRQVDIGNLVTSGDTTPLVVITQVKPISVVFSLPQQQIGTVVEQMNGPGKLTVTALDRNQDKVLAEGTLTTLDNQIDTTTGTVKLKARFENADGKLFPNQFVNVRLLAQTLKGVLTIPANAVQRGTNGIYVYVVGADNKVSQRSVAIGTSENERVVVESGLKAGEQVVVEGTDRLRDGMEVRVAEASPQVLEGEPQKPQTGRPSGLQGDSVGSGSAE	24.41	gnl|BL_ORD_ID|2242|hsp_num:0	2717			234	333	erythromycin; tetracycline; novobiocin; aztreonam; kitasamycin; rokitamycin
BGC0000130.1|Pyrrolomycin_16 # 18529 # 18708 # -1 # ID=1_16;partial=00;start_type=GTG;rbs_motif=GAG;rbs_spacer=6bp;gc_cont=0.567	BGC0000130.1|Pyrrolomycin_16 	18529	18708	-	Loose	700	21.557	ADC-177	22.81	3006349	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	ADC beta-lactamases pending classification for carbapenemase activity	GTGGCGAACCGAACGCGGTCGTCATTACGGATCGCGGGGCCCGACCGATTATGGTCGGGCCCCGTTTTCGTCTCTTCTTTCGATGACTTCCCGCCAGAACCGAACGAATCTGCGACCTTTTCCCTCGGATCTTTTCAAGAAGTGGGACGGTTGTTCTATGGAGTGTTCGCATGGGCGTGA	MANRTRSSLRIAGPDRLWSGPVFVSSFDDFPPEPNESATFSLGSFQEVGRLFYGVFAWA	MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNNKKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKELKNTPIDQVNLLQLATYTSGNLALKFPDEVKTDQQVLTFFKDWKPKNSIGEYQQYSNPSIGLFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGPLDAPAYGVKSTLPDMLSFIHANLNPQKYPADIQRAINETHQGRYQVNTMYQALGWEEFSYPATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTTGFGTYVVFIPKENIGLVMLTNKRIPNEERIKAAYAVLNAIKK	15.40	gnl|BL_ORD_ID|3192|hsp_num:0	4245			396	549	
BGC0000130.1|Pyrrolomycin_18 # 20001 # 26696 # -1 # ID=1_18;partial=00;start_type=ATG;rbs_motif=GAGGGA;rbs_spacer=8bp;gc_cont=0.730	BGC0000130.1|Pyrrolomycin_18 	20001	26696	-	Loose	600	29.6462	RSA2-1	28.69	3006981	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	RSA2 beta-lactamase	ATGACGACGACGCAGAGCGGCCCGGCGCAGGAGTACCGGACCCGGCTCGTCGAGGCCCTGCGCACCATCGAGCGGTTGCAGGACCGACTGAAGAAGGCCAACGACCGCCCGCAACGCCTCAGTGAGCCCATCGCCATCGTCGGCCTCGGCTGCCGGCTGCCCGGGGGCGCGGACAGCCCCGAGGCGTTCTGGCGGGTCCTGCGGGACGGGGTGGACACCACCTCCGAGTTCCCCGCGGAACGCGGCGACGCCTCGGCGCTGTACGACCCGGACCCCGACGCGCCCGGCAAGGCCTATGTGATCAGGGGCGCCTTCCTGGGCCGGGTGGACACCTTCGAGCCCAGCGTCTTCGGCATCTCGCCGCGCGAGGCGCTGGGCATGGACCCGCAGCAGCGCATCACGCTGGAGGTCGCCTGGGAGGCGCTGGAGCGCGCCGGCTACGCGCCGGACAGCCTCTCCGGCAGCGCCACCGGCGTCTACCTGGGGCTGAGCACCACCGACTACGTACGGATGCGGCAGAGCGAGGGCGACATCCGTGACGTGGACGCCTACCAGCTCGTCGGGGAACCCAGCTTCGCGGCCGGCCGGATCTCCTACACCCTGGGCCTGCAGGGCCCGAGCAAGGTCATGGACACCACCTGTTCGTCCTCGCTGGTCGCCCTGCACGAGGCGTGCCAGGGCCTGCGCCTCGGCGAGTGCGACATGGCGCTGGCCGGTGGTGTCAACCTGATGCTGTCGCCCTACGGCTTCGTCATGATGAGCAAGTTCGCCGGGCTCTCCCCGGAGGGCCGCTGCAAGACGTTCGACGCCAGCGCCGACGGGTACGCCCGCGGCGAGGGCTGCGGCGTGGTCGTGCTCAAGCGGTACTCCGACGCGCTGCGCGACGGGGACAACGTCATCGCCCTGGTCCGCGGCACCGCGGTCAACCACGACGGCCGCAGCAGCGGACTCACCGTGCCCAACCCGGCCGCCCAGCAGGACGTGATCCGGGCGGCACTGGCCCAGGCCGGCATCGCCCCCGGCGACGTGGACTACGTGGAGGCGCACGGCACCGGGACCGCGCTCGGCGACCCCATCGAACTGCGGGCGCTGGAAGCGGTCATCGGCCGCAACCGGCCGGCGGGCTCCCCGTTGCTCGTCGGCTCGGTCAAGACCAACATCGGGCACCTGGAGTCCGCCGCGGGCGTCGCCGGGCTGCTCAAACTGGTGCTGGCCCTGCAACACGGCCAGATCCCGCCGCACCTGCACTTCACCGACCCCAACCCCAACGTGGACTGGAGCCGGCTGCACATCGAGGTCACCGCGCAGGGCCGGCCCTGGCCGACGAGCGACCGCCCGGCCATCGGTGCCATCAGCAGCTTCGGCGCCAGCGGGACCAACGCCCACGCCGTGGTCAGCGCCCCGCCGGCACCCGCCGGGAACGGACAGAACGGGGTCACCCGCGACGTCCTGGTGCTCTCCGCGAACACCGAGGAGTCGCTCACCGAACTCGCCCGGAAGTACGCCCTGCACCTGCGCCGCGAACCCGACCTGACGCTCGGCGACGCCTGCCACACCACCCAGGTGGGCCGGTCCCGGCAGAGCTACGGCCTGGCCGTCGCCGGCGACTCCCTGGACTCGCTGGCCGACGCCCTCGACGCACACCTGCGCGGCGGCCGGGACCCCCGGGTGGACACCGCCAGGTTGCCCGTGCACAAGTACCGCAAGACCGGCTGGCTCTTCACCGGGCAGGGCGCCCAGTACGCGCAGATGGCCCGGGGCCTCGCCGACGAGCCCGCGTTCCGGGAGGCGTTCGACGCCTGCGCGGAGCTGTTCGACCCGCTGCTCGGCCGGTCGCTGGCCTCGGTGGTGTGGCCGGAGCCCGGCACCGAGTCGCCCATCGACGACACCCGCTACACCCAGCCGGCGCTCTTCGCCGTCGAGTACGCCCTGGCCCGGATGTGGCTCGGCTGGGGCCTGAAGCCCAGCGCCCTGCTCGGACACAGCATCGGGGAGCTCGCCGCCGCCTGCATCGCCGGGGTGTTCTCCCTGCCGGACGCCGTCCGGCTGGTCGCCGCCCGCGCCTCGCTGATGGCCGACCTCCCCGCCGGCGGCGCCATGGCCGCGGTCCACTGCGACGAGGCCACCGCCCGCAGGGCCATCGCCGACCACCCCGACACCCTGTCCCTGGCCGCGGTCAACGGGCCGCACACCGTCACCGTCTCCGGTGTCGCCGCCGACCTGGACGCGGTCCTCGCCACCCTCAAGGAACAGGGGGTGCGCAGCCAGCGGCTCACCGTCTCGCACGCCTTCCACTCCCCGCTGCTGCGGCCCATGCTCGACGAGTTCCGCAGGGTCGCCGGGACCATCACCTACGCGGCGCCCACCATCCCGCTGTACTCCAACGTCACCGGGCAGTTGTGGACGGCCGCCGAGGTCGGCCCGGAGTACTGGGTGCGGCACGCCGCCGGCGCGGTCCGCTTCCACGACGGGATCACCGGACTCCACGCCTCAGGGGTGCGCACCTTCCTCGAGGTCGGACCCGCCCCCGTGCTCGTGGGGATGGGCAGCAGGGCCGTGGAGGACCCGGACTGCACCTGGATCGCCTCGCTGCGCCGGCCCACCCGCAAGGGCGCCTCGCTGCACGACCAGGACAGCGTCCGGCAGGCGCTGGGACTGCTCTACCTGCGCGGCGGCACCGTGGACTGGGCCGCGGTGCACGCCGGCCAGAACCCGCGCCGGGTCCCGCTGCCCACCGCGGTGTGGCGCGGCGACTCCTACTGGTTCGCCGAGCGCCGCAAGGACGCCGAGGCCGCGCCGGCGCCCCGGGCCGGCACCGTGGTGCCGTCGATCGGGCTCCGCCTGCACAGCGCCGTGCCCACCTACGAGGTGAACCTCGACGACGCCCGCTGGGAGCCGTACGCCCGGCAGGCCACCGACGGCCGCAGCTACCTGCCGGTGGGCGCGCTCGCCGCGGTGATGCAGGACGCGGTGGCGGACGCCTTCGGTGGGCGCTGGGACTGCCTCGAGGAGCTCATCATCGACCAGCGCATCCCCAGGGACGGGGACGGCCGGATCGTGCAGATCACCCTGCGCTCGACCAGCGACGGCCACGCCACCTTCGAGTGGCACAGCATCACCCCGGACGAGGAGGCCGCGGGCGCCCCCTGGAAGCTGCACGGCCACGGCCTGCTGCGCCGCCGCGCCTCGGGCCGCCGCCTGGCGCCCGAGCTCCAGGTCCACCGCTACGGGGACGCCGTCAGCTACGAACCCGCCGCGCTGTCCTCGGCGCTGGCCGGAGCGGTCACCGGGGCCTCGCGGGGCGGCGGTGGCGTCCTGGTCGCCCTCGCCCCGGAGCGCGCCGAGGGCGGGCTGAGCTGGGTGGAGATCGTGGACGCCGCGGTCGCCGCGCTGTCCTGGGACGCCGGGGTGGACACCCAGGAGGTCGGCTTCACCCGCCGGGTCAGCGACCTGATCTGCGAGGACCCGCGGCGCGTCGCCTACGTGCGGGCCACCGCCCACCGGACCACGGGCACCTCCGAGCACCTGCACGAGGTGCTGGGCGGCGCGGAGTTCTTCGCCGAGGACGGCGCCCACATCGGCAGCATCGGCGAGTTGCTGGTGGTTGGCAACAAGGCCGCGCCGGCGCAGAGCGCCCCGTGGCGGCACCCGGACGAACTGCTCCAGCGGGTCGAGTGGCAGGTCGCCCCGGCCCCGCCGTCCCCCGGACGCCTGGACGACGAGAACTGGCTGCTGGTTCCGGACCGTGACGGCGTCGCCGACCGGCTCGCCGAGGAGCTGCGCCGGCGCGGGGCCCGCTGCCTGGTCGCCGCACCCGACGTGGCGGGCACGGACCGGGCGGCGGTGACCGAGCTGCTCGCGCGCTGGCGGGACCAGTCCGTGCCGACCGACACCGCGGACCGGATCGTCCTGCTGACCGGCCTCGACGCGCCCGAACCCGAGGCCGCCGACGCCGAGGCGCTGGTGGAGTACCGGGACCGCACCGAACTGACCGTGGTGTCCCTGGTGCAGGGGCTGCTGGCCCGCGAGGACTGCGCCAAGGCCACGGTCTCCTTCGTCACCCGGGGCACCATGCCGGCCCAACGTGCCCGGGGCGACGTCAGCTCCCCGTTCGGCAACACCCTGTGGGGGCTCGGCCGGGTGGTCGCGCTGGAGCACCCCGAACACTGGGGCGGAGCGGTGGACCTGGACCCGGCGGGTCCGCTCACCGACGACGTCGCCAGACTCGCGGACGCCCTGCTCGACGTGCGGGCCGAGGACCAGCAGGCGCTGCGCGGCGACACCCGCTACGTGGCGAGGCTGGTGCCGCACAGCGTCACCCAGGAGGAGCTGCGGAGCACCCCGCCGGTCAGGTCGTCGGCGTCGTACCTGATCACCGGCGCGTTCGGTGGGATCGGCCGGGCCCTGTCCCGCTGGCTGGCGATCAACGGCGCGGGGAAGCTGGTCCTGGTGGGCCGGACCCCGCTGCCGCCGCGGACCGACTGGGACATGCCGGGGCTCTCCCAGGCGGTCCGGGAGCGGATCGACCTGGTCCGGGAGTTGGAGGCCACCGGTGCCCTGGTCGAGGTGGCCGCCGCGGACGTCTGCGACCCCGCCCAGTTGCTGCCGGTCATGGAGGACCTGGCGGTGGACTCCCGCCCGTTGGCCGGCGTGGTGCACGCGGCGGGTCTGTCCGTCCCACAGTTCCTGCGCGACATCACCGTGGAGACGCCCGACGACTACGACGCGGTCTGGCGTCCCAAGGTCGTCGGTGGCTGGCTGCTGCACCAACTGACCGAGGGCGCGGAGCTCGACTTCTTCCTCGGGTTCTCGTCGATCGCCGCCACCTGGGGCTCCCAGCACCTGTCCAGCTACTCCGCGTCCAACGCGTTCCTCGACGGGCTCGCGGAGTACCGGCGGGGGCTCGGACAGGCCGCGCTCACCGTGAGCTGGGGCCCCTGGGAGCTGGAGTCCAACCTGTTCGGCGAGGACGTGCTGGCGTTCTTGATGTCCACCGGGCTACGGACCCTGTCCGCGCCGCAGTGCCTGAAGCTGCTCGGCGCGCTGCTGCTCGGCAGCGAGCCGCAGGCGGTGGTCTGCGCCGCGGACTGGGCCACCTACAAGCCGGTGATGGAAGCCAGGATCGAACGTCCGCTGCTGCGCACGCTCCAGATCGTCGAGGACTTCGGGGACGACGCCGGGTCGCCGGTGTTGGAGGAGATCGGCCGGGCGGCCGGTCCGCGTGAACGCGTCGAACGACTCGTCGGCTACCTGCGGGACGTCCTGGGTGACGTGCTGTCGGTCAGTGCGGACGCCATCGAGCCGGAGGCCGACGTGATGTCCCACGGCCTGGACTCGCTGATGGTGATGGAGGTCGTCAAGCGCTGCAAGAAGGACCTGCGGGTCAGCGTGCGCCCCAACCACCTGTTCGAGCGGTCCACCCTGGTGGACTGGGCTGACCTGCTCTCCGGTGAGCTCGGCGGGGCGGGCGACGACGACTCGGCCGCGGCGGAGCCCACGGAGGCGGTGATGGCCGACCCGGCGAACATCGCCGAGGACGTCTCCCTCGCCCCGGACATCGTCCCGGAGGGCCCCCTACGGGACGGTTACCAGGACCCCCGCCAGGTGCTGCTCACCGGCGCCACCGGCTTCCTCGGCGCCTACCTGCTGGACGAGCTGCTGGCCACCACGGAGGCGACCGTGCACTGCCTGGTGCGGTGTCAGGACCCGGCCGACGGGCTCGCCCGCATCCGGGCCAACTACGAGAAGTACCTGCCCTGGCGCACGGAGTCCGAGGACCGGATCTCGGTGCTGCCGGGAGACCTGGAGAAGCCCCTGCTCGGCCTCCCGGACGAGCAGTTCGACACCCTCGCCCACGAGCTGGACGCGATCTACCACAACGGTGCCTGGGTGAACTTCACGTACACCTACGAGCAACTGCGGGCCGCCAACCTGGCCGGGTGTGAGGAGATCCTGCGCCTGGCGTGCCGGGGGCCGCTCACCCCGGTCAACCACATGTCCACCTACGGCATCTGGGGTCTGCCGGCGGACGGCCGGACGGTGATCAGGGAGACCGACGACATCACCGGCGCCGGGAAGCTGGTCACCGGCTACGTGCAGACCAAGTGGGCCGCCGAGCGGCTCATGGAGATCGGCCGGTCCCGGGGCATCCCGGTGGACATCCACCGACCGGGCCGGGTGCTGGGCGACTCCCGCACCGGGGCCGCGCTGACCACCCACTTCACCACCCGGGTGATCAAGGGGTGTATCCAGCTCGGTATCGCGCCGGCGCTCGACCTGGAGATCGAAATGACGCCGGTGGACTACGTCGTCCGGTCGTTGGTGCGCATTTCCCGGGAGCCGCACGCGTTCGGGGAGACCTACCACCTCGTCAACGGGCGCAAGATGACCTTCGAGCGGCTGATCCGGGCGATCACCGGGTACGGCTGGAAGGTCGAGGTCGTACCGGTGGACACCTGGTGGGGCACCCGGCTGCAGGACTCCTACGCCGAGCAGGACAACGAACTGCACCCCGTGATGGAGGTCGTCGAGGAGTTCGTCGTCGGTGGCGAGGAGGCCATCGACTACGACGACAGCAACGCGGAGCGCGTGCTCAAGGGAACGGGAATCAGTTGCCCGCCGCTGGACGAGGCGCTACTCGGCACGTATTTCGACTGGATGGTGCGCAGCGGCTATCTGCCCGAGCCGCGCGGCTGA	MTTTQSGPAQEYRTRLVEALRTIERLQDRLKKANDRPQRLSEPIAIVGLGCRLPGGADSPEAFWRVLRDGVDTTSEFPAERGDASALYDPDPDAPGKAYVIRGAFLGRVDTFEPSVFGISPREALGMDPQQRITLEVAWEALERAGYAPDSLSGSATGVYLGLSTTDYVRMRQSEGDIRDVDAYQLVGEPSFAAGRISYTLGLQGPSKVMDTTCSSSLVALHEACQGLRLGECDMALAGGVNLMLSPYGFVMMSKFAGLSPEGRCKTFDASADGYARGEGCGVVVLKRYSDALRDGDNVIALVRGTAVNHDGRSSGLTVPNPAAQQDVIRAALAQAGIAPGDVDYVEAHGTGTALGDPIELRALEAVIGRNRPAGSPLLVGSVKTNIGHLESAAGVAGLLKLVLALQHGQIPPHLHFTDPNPNVDWSRLHIEVTAQGRPWPTSDRPAIGAISSFGASGTNAHAVVSAPPAPAGNGQNGVTRDVLVLSANTEESLTELARKYALHLRREPDLTLGDACHTTQVGRSRQSYGLAVAGDSLDSLADALDAHLRGGRDPRVDTARLPVHKYRKTGWLFTGQGAQYAQMARGLADEPAFREAFDACAELFDPLLGRSLASVVWPEPGTESPIDDTRYTQPALFAVEYALARMWLGWGLKPSALLGHSIGELAAACIAGVFSLPDAVRLVAARASLMADLPAGGAMAAVHCDEATARRAIADHPDTLSLAAVNGPHTVTVSGVAADLDAVLATLKEQGVRSQRLTVSHAFHSPLLRPMLDEFRRVAGTITYAAPTIPLYSNVTGQLWTAAEVGPEYWVRHAAGAVRFHDGITGLHASGVRTFLEVGPAPVLVGMGSRAVEDPDCTWIASLRRPTRKGASLHDQDSVRQALGLLYLRGGTVDWAAVHAGQNPRRVPLPTAVWRGDSYWFAERRKDAEAAPAPRAGTVVPSIGLRLHSAVPTYEVNLDDARWEPYARQATDGRSYLPVGALAAVMQDAVADAFGGRWDCLEELIIDQRIPRDGDGRIVQITLRSTSDGHATFEWHSITPDEEAAGAPWKLHGHGLLRRRASGRRLAPELQVHRYGDAVSYEPAALSSALAGAVTGASRGGGGVLVALAPERAEGGLSWVEIVDAAVAALSWDAGVDTQEVGFTRRVSDLICEDPRRVAYVRATAHRTTGTSEHLHEVLGGAEFFAEDGAHIGSIGELLVVGNKAAPAQSAPWRHPDELLQRVEWQVAPAPPSPGRLDDENWLLVPDRDGVADRLAEELRRRGARCLVAAPDVAGTDRAAVTELLARWRDQSVPTDTADRIVLLTGLDAPEPEAADAEALVEYRDRTELTVVSLVQGLLAREDCAKATVSFVTRGTMPAQRARGDVSSPFGNTLWGLGRVVALEHPEHWGGAVDLDPAGPLTDDVARLADALLDVRAEDQQALRGDTRYVARLVPHSVTQEELRSTPPVRSSASYLITGAFGGIGRALSRWLAINGAGKLVLVGRTPLPPRTDWDMPGLSQAVRERIDLVRELEATGALVEVAAADVCDPAQLLPVMEDLAVDSRPLAGVVHAAGLSVPQFLRDITVETPDDYDAVWRPKVVGGWLLHQLTEGAELDFFLGFSSIAATWGSQHLSSYSASNAFLDGLAEYRRGLGQAALTVSWGPWELESNLFGEDVLAFLMSTGLRTLSAPQCLKLLGALLLGSEPQAVVCAADWATYKPVMEARIERPLLRTLQIVEDFGDDAGSPVLEEIGRAAGPRERVERLVGYLRDVLGDVLSVSADAIEPEADVMSHGLDSLMVMEVVKRCKKDLRVSVRPNHLFERSTLVDWADLLSGELGGAGDDDSAAAEPTEAVMADPANIAEDVSLAPDIVPEGPLRDGYQDPRQVLLTGATGFLGAYLLDELLATTEATVHCLVRCQDPADGLARIRANYEKYLPWRTESEDRISVLPGDLEKPLLGLPDEQFDTLAHELDAIYHNGAWVNFTYTYEQLRAANLAGCEEILRLACRGPLTPVNHMSTYGIWGLPADGRTVIRETDDITGAGKLVTGYVQTKWAAERLMEIGRSRGIPVDIHRPGRVLGDSRTGAALTTHFTTRVIKGCIQLGIAPALDLEIEMTPVDYVVRSLVRISREPHAFGETYHLVNGRKMTFERLIRAITGYGWKVEVVPVDTWWGTRLQDSYAEQDNELHPVMEVVEEFVVGGEEAIDYDDSNAERVLKGTGISCPPLDEALLGTYFDWMVRSGYLPEPRG	MANTTICRLCAVSQAGLSLGETLIKGQVMSFLRSAAIFAAVLLPLSAHAADLDQTIEALENRLDARIGVAIHDTGTGKVWGHREDERFLMNSTIKVPLCAAVLSRSDVDLSEELPVRAEDILEYAPVTEQHVGGTMTVADLCFATIDQSDNTAANLLFGRLGGPESLTTFLRSIGDDLTRSDRLEPDLNIWSAGDPRDTTTPAAMVRTLEAMLTGDALTATAREQLADWMRPGGVTGALMRPSVPHNWDVADKSGSGSNTRNLIAMLTPPDGAPIFVSLSISEAEVDFATRNAALVELSAAVVRSLHAQN	719.68	gnl|BL_ORD_ID|4568|hsp_num:0	5638			261	582	
BGC0000130.1|Pyrrolomycin_19 # 26699 # 33202 # -1 # ID=1_19;partial=00;start_type=ATG;rbs_motif=GGGAG;rbs_spacer=7bp;gc_cont=0.756	BGC0000130.1|Pyrrolomycin_19 	26699	33202	-	Loose	700	28.1054	PDC-372	32.1	3006743	protein homolog model	n/a	n/a	monobactam; carbapenem; cephalosporin	antibiotic inactivation	PDC beta-lactamase	ATGCCTCAGCCGACCACCCACCGCAAGCGCGCTTCCCTCCCCACGTCCACGTCCGCGAGCATCCCCGCCCCGCGTCCCGACGACATCGCCGTGGTCGGTGTCGGCTGCCGGTTCCCCGGCGGGGTGCGGGGCCTCGACTCGCTGTGGAACGTTCTGCTCAACGGTGTGGACGTGGTGGACAAGGTTCCTCCCGACCGCTGGGACGAGAGTTTCTTCCACGACGATCCGAGGAACCCGGGCACCACGTACTGCCGCGAGGGCGGATTCCTCACCGACATCGACCGTTTCGACGCCGACTACTTCGGCATCTCCCCCCGCGAGGCCAGGGAGATGGACCCCCAGCAACGCCTGCTGCTGGAGGTCACCGCCGAGGCCATGGACGACTCCGGGCTGCCCAGGCAACGGTGGGAGGGCACCCGGACCAGCGTGCACATGGGCATCCTCGGCTCCGACTACCTGCTGGTGCACACCAAGGCGGCGGGCACCCGGACGATCGATCCCTACTTCGCCAGCGGCAAGGAGTTCAGCTTCGCCGCCGGCCGCATCTCCTACGTCTTCGGTCTGCACGGCCCGGCCATGACGGTCAACACCGCGTGCTCGTCCTCGCTGGTCGCGGTCCACCTGGCCTGCCAGAGCCTGCGCAACCACGAGGTGGACACCGCGCTCGCCGGCGGCGTGAACGCCATCGTCGCCCCCGAACTCACCGTGTTCATGGGCAAGGTGCAGGCGCTGTCCCCCACCGGGCGGTGCAAGCCCTTCGACGCCGCCGCCGACGGCATCGTCCGCGGCGAGGGCTGCGGCGTGGTGGTGCTCAAACGGTACGCGGACGCGGTGCGCTCCCACGACCAGATCTACGGGGTGATCCGGGGCAGCGCGGTGAACCAGGACGGGCGCAGCGCCGGACTCACCGTGCCCAACGCGGTGGCCCAGGCCGCCCTGCTCCGCCAGGCCCTGGACTCCGCGGGCCTCGACCCCAGGGTGCCCTCGTACGTGGAGGCGCACGGCACCGGCACCCCGCTCGGCGACCCGTTGGAGATCTCCGCGCTCGCCGAGGTGCTGGGCCGGGAGCGTCCCGCCGGCCGCCCGCTGCTGGTCGGCTCGCACAAGGCCAACTTCGGACACATGGACTCCGCGGCGGGGATCGCCGGGTTCCTCAAGTCCCTGCTGGTGCTGCGGCACCGCACGGTCCCCCCGCAGATCCACCACCACCAGCCGTCCCCGCTGGTGGACTGGGCGTCCTCCGGCATAGCCGTGCCCACCGAGGCCACGGAACTTCCCACCCGGCGCGGCCACGCGGTCGTCGGCGTCAGCGCGTTCGGCCTGTCCGGCACCAACGCCCACGTGCTGGTCTCCACCCCTCCGGCCGGCCGCAGGACCACCCACAGGGCCCCGTCGGGGCCGCGCACCCTACTGCTCTCCGCCTCCACCGAGGAGGGCCTGCGGGAACTCGCCGCCGACTACCGCGCGCTGCTCGACGGCCCCGTGTACAGCGGCACCCGCCCCGTCGACATCGACCAGGCCCTGGCCGCCGCGGCCCTGCGCCGCACCCACCACCGGCACCGGCTGGCCGTGGTGGGCGAGGACACCGCCGCCCTGTCCGCCGCCCTCACCGACTTCCAGGAGGGCCGCCGCCGCCCCTCGGTGTTCACCGCGGAGGCCGACGACAGGCGCCCCGCACCGGTGGTCTACGTGTTCTCCGGACAGGGCTCCCAGTGGCCCGGGATGGCCCGTGACCTGTACCGGGAGGAACCGGTCGCCCGCAGGGCGCTCGACGAGTGCGAGGCGCTGATCCGTGAACACGCCGGGTGGTCGCTGCTGGACGCCCTCGCCGACCCGGACCCCGATCGGCTGAAGGCCACCGAGGTGGCCCAGCCCGCGGTGTTCGCCGTGCAGGTCGCCCTGGCCCGCCTCTGGACCTCCTGGGGAGTCAAGCCGGACGCGGTGATCGGTCACAGCATGGGCGAGGTGGCCGCCGCCTGCGTGGCCGGCGCCCTCTCCCTCCCGGACGCCGTCCGACTGATCGTCGCCCGGGGCCGGTTGATGCAGCGGGCCACCGGCACCGGACGCATGGTCAACGTCGAGGCGAGCGCCGAGGACGTGCGCGCGACCCTGGACGAACGCCACCCCGAGGTCTGCGTCGCCACCGTCAACGGCCCGCGCTCGGTCGTGGTCGCCGGCCCCGGCGAGGCGGTGGACAAGGCGGTGGCCGAGCTCAGGGCCGGTGGCGCCAGCACCATCGCGCTCCCCGTGGACTACGCGTTCCACAGCCCGCTGATGCGCCCCTACGGGGACGAACTGGAGAGCCTGCTCGGCTCGCTGCGCCCGGCGGAACCCGGGGTGCGGATGGTCTCCACCGTCGCGCCCGACGAGCCCCTGCCCGCCCTCGACGCCCAGTACTGGGGCCGCAACCTGCGGGAACCGGTGTTGTTCTGGCCCGCCGTGGACCAGGTGCTCGCCGAAGGCGACGCGGACTTCGTGGAGATCGGTGCCCACCCGGTGCTGGGCCGCCCGCTGCAGTCCGCGATCACCGAACGCGGGCGCGGCGGGGCGGTGGTGGGCTCCCTGACCCGGGACAAGGCGGCGCACACCACCCTGGCCCACGCCCGTGCCCGGCTGCACACCGCCGGGGTGGCGGTGGACTGGGCGGCGCTGCTGCGCGGGCCGGTGAGGCCCGCCGCGCTGCCTCCGCACCGCTGGGCCGACGAACGGCACTGGCTGTCCGGGGTCCACCGGGGACAGCAGTCCTCCGGCGGTTTCTCCGCGGAGGGCCTCAGCGCCCAGGTCCGGCTCTTCGACGCCGCGGGCACGTTGGTCGGGGAGATCGACGCGGGCGCCGTGGCCACCACGGCGACGCCGCGCGGCACCGGGGCCAACGGCACACCCGTCAACGGGGCCGCGCCGAACGGCACCGGTCCCCTCAGCGCCACCCCGACCGTCGCGCCCCAGGCCGCGGCACCCGCCGGGCCCGCCGCCGCGCCCGACCAGCAGGCGGCGGTGACCGCGCCCTGGGACCGCGAACAGCTCGCCGCCGCGGTGCAGGGCGCCCTGGCCACGGTGCTCGGCCACGCCCCGGGCAAGCGGCTCCCGGTCACCCGGGGCTTCTTCGAGTTGGGCATCGACTCCATATCGGTCGCCGAACTCGCCCGCCAGGTCGAGGAGGCCGTGGGCGTGCCGCTCGACGGTGCCGACGTGCTCTCGCACGCCAGCGTCGAGGCGCTGACCGACTACCTCGTCACCCTGGACCCACCGCCCCGGAACGCGCCCGGCCGGCGCCAGGCGCCGGACCAGCCGGCCGGCGACGCCCCCGCCCCGGAGGCCGGCCCGCAGGTGACACCCCGGCAGGACTCCGGCGGGGTGTCCGAGCGGCCGGCGGCCGACGTGCGGACGGTCGAGCCCGCGGCACCCGCCGCGCCCGCCCCCGCCGACCAGCCGCCGGCGGGGCCCGAGCCGATCGCGATCGTCGGCATCGGCTGCCGACTCCCCGGGGGAGCTGACGGCCCGCAGGCGTTCTGGCGGCTGCTCAGCGACCGCACCGACACCACGGGTCCCGTTCCGGCCGACCGGTGGAACGCCGCCGAACTGCTGGCCCGCGGAAAGGTCACCCCCGGCACGGTGGCCACCGCGCGGGGGGCGTTCCTCGACGGGGTGGACGGCTTCGACCACGGCTTCTTCCGCGTCTCGCCCCGTGAGGCGCGCAGCATGGACCCGCAGCAGCGGCTGTTCCTCGAGGTCGCCTGGGAGTCCCTGGAGGACGCAGGCATCCGCACGGAACTGCTGCGCGGTGGGCGCACCGGGGTGTTCGTCGGCCTCAACACCACCGACTACCAGCAGTTGGTGACCCGGGACCACAACGACGTGGACCTGTACTACGGCACCGGGAACTCGTTCTGCGGCACCGCGGGCCGGCTCTCGTACTTCCTCGGCGTGCGCGGGCCGAGCATCGCCGTGGACACCGCCTGCTCGTCCTCGTTGACCGCGATCCACCTCGCCTGCCAGTCGCTGCGCGCCGGGGAGAGCGACCTGGCGGTCGCCGGGGGCGCCAACGTGATGTCCACCCCGACGGTGTTCCTGGCGATGTCGGCGGCCGGGGCGCTGGCACCGGACGGACGGTGCAAGACCTTCGACGACTCGGCCGACGGGTACGGACGCGGCGAGGGCGCCGGCGCGCTGGTCCTGAAGACCCTCTCCCGCGCCGTCCGCGACGGTGACCGGGTGTACGCCGTCATCCGCGGCAGCGCGGTCAACCAGGACGGGGCCAGCGGCGGCCTGACCGTTCCCAGCGGCGAGGCCCAGGAGGAGGTCATCCGGGCGGCGCTCGAGCAGGCCGGCGTCCCCGCGGAGCACGTGGACTACGTGGAGGCGCACGGCACCGGCACCAGGCTCGGCGACGCCATAGAACTGCGGGCGCTCGCCGGGGCGCTGGGGTCGGGGCGTGCCCCGGACCGGCCGCTGCTCGTGGGGTCGGTCAAGACCAACGTCGGGCACCTGGAGGCGGCGGCCGGCGTCACCGGCCTGATCAAGACCGTGCTGGCGCTCAACCACCAGGAGATACCCGCGCACCTGCACGTGAAGACCCCGACCCGCCAGGTCGCCTGGGACCGCCTGCCGGTGCGCGTGGTCACCGACGCCACGGCCTGGCCCCGCGGCGACCGGCCGCGGCTGGCCGGGATCAGCGCCTTCGGGTTCACCGGGACCAACGCCCACGTGGTGGTGGAGGAGCCGCCGGCCCCGGTCGGCCGGCCGGCGCCCCAACCCGGGACGGGGCGGCCCCTGGTGCTGACGGTGACGGCGGTGAGCGCGGTGGCGTTGCGGGCCACCGCGGGCCGGTGGGGCGAACGGGTCGCCGCCGCCCGTGACGACGAGCTGGCCGACCTGTGCTGGGCCTCGGGGGCGCGGCGCACCCACCACGAACACCGGGTGGCGGTCGTCGCCACGACCCGCCGGGAGCTGGCGGACGCCCTGGCCGCGGTGGCCAGGTCCGACACCGCGGACGGGGTGGTCCTGGGCACCGGACGCCCCGGGGAGTACCGCAGGCTCGGCTTCCTGTACGGCGACACCGTGCCCGACCTGCCGTGGGCCGAGCTGCTCGGGGCGGCCTCGCCGGGGAGCGGGGACGGCGGCACCGCGCGGACCCTGCTCGGCGGTTCCGACGCCGCCGCGGCGTTCCGCGCCGAGGTGGTGGACGTGGACGCGGCACTGCGCGACGCGCTGGGCTTCTCCCCGGTGCGGGCCTGGGAGACCGGCACGCTGCCCGAGCCCGGTTCGACGCAGCACGAGGCGCTGGTCCTCGCCGGGCAGTTGACGGGGACGGCGCTGTGGTCCCGGCTGGGGATGACCCCCGACACGGTGGCCGGCCACGGGGTGGGGGAGTACGCCGCGGCGGTGGCCGCCGTCGAGCTGACCGCCACCGAGGCGGTGCACCGGTTCGCCGCCGGTCGAGGGGTCGGTGAGCCCGGCGGGCCCGGCGTGCTGACCCGTCACGCGGCGTCGGCCGGCTGGCCGGCGATCGGTGGCCTGCTGGCCCAGGACGGCGTGGAGGTGCTCCTCGCCCTCGGGGTCGGTGAGCCGGAGGCCGAGCGGGTGTCCGCCGCGTTCGCCGGCAACGGTTCCGAGGTGCGGGTGCTGCGGCTGCGCGGGCGGGGCCTCGACCCGCTGCGCACCGCCGCCGAACTCCAGGTGCACGGCTGCCGGGTGGACTGGGACGGGCTGCTGCCGCAGGCGCACCGGATGGTGACCCTGCCGACCTACCCGTGGCAGCGCCGCAGCCACTGGATCACGCCCCTGGCCCCGGCGGCCGACCCCGTGACGGCTCCGGCGACCACCGCGCCCACGGACGGCGGCCCGCTCCCGTCGGTGAACGGGGCGGCTCCGGAGGCCACAGCCCCGGTCCCCGCCCCGCCTGTCGCCGCCCCGCCCGTCCCCGCCGGCCCCCCGGTGTCCGCCCAGGGCGCCCCGGGCGCCGCTGACCGGCCCGAGGACGCCGCTGGCCGCCCCGTCACCCCGCTGGTGGCCGAGTTGACCGCGTTGCCCGCCGAGGCCCGCGCGGAGCGGCTGCTGACCACGCTGCTCGACCTGGTCGCCGAGGTGCTGGGGGGAGCCGACGACGTCGCCCCGGAACAGGGCTTCTTCGAACTGGGTGTGGACTCGGTGCTCGGCGCGGAACTCAAGGAGCGGGCCGAGGACCAGTTGGGCAGGGAACTGCCGGGAACGATCATGTTCGAGTGTCCGAACGCCCTTTCGTTCGCTGAGTTCATCCTCGACGACCTGTTCGGCGGGGCCGAGCCGGAGACCGGGCCGCCGGCCGCGCCGGGCAACGCCGCCCCCCGCCCCGACGGCGCCGGCGCGGCCGGCACCGCCGCCAGCGCAGGGGACGGCGCGGTATCCGGCGCGGAGGACGTCGCCGAAGGGGACGACGGCCTCGACGACCTCAGTGACGACGCGCTGATGGGGCGCCTGCTTTCCGCGCTCTCCAGCTCCGAAGCCCTGCTGACCGAGGGAGACTGA	MPQPTTHRKRASLPTSTSASIPAPRPDDIAVVGVGCRFPGGVRGLDSLWNVLLNGVDVVDKVPPDRWDESFFHDDPRNPGTTYCREGGFLTDIDRFDADYFGISPREAREMDPQQRLLLEVTAEAMDDSGLPRQRWEGTRTSVHMGILGSDYLLVHTKAAGTRTIDPYFASGKEFSFAAGRISYVFGLHGPAMTVNTACSSSLVAVHLACQSLRNHEVDTALAGGVNAIVAPELTVFMGKVQALSPTGRCKPFDAAADGIVRGEGCGVVVLKRYADAVRSHDQIYGVIRGSAVNQDGRSAGLTVPNAVAQAALLRQALDSAGLDPRVPSYVEAHGTGTPLGDPLEISALAEVLGRERPAGRPLLVGSHKANFGHMDSAAGIAGFLKSLLVLRHRTVPPQIHHHQPSPLVDWASSGIAVPTEATELPTRRGHAVVGVSAFGLSGTNAHVLVSTPPAGRRTTHRAPSGPRTLLLSASTEEGLRELAADYRALLDGPVYSGTRPVDIDQALAAAALRRTHHRHRLAVVGEDTAALSAALTDFQEGRRRPSVFTAEADDRRPAPVVYVFSGQGSQWPGMARDLYREEPVARRALDECEALIREHAGWSLLDALADPDPDRLKATEVAQPAVFAVQVALARLWTSWGVKPDAVIGHSMGEVAAACVAGALSLPDAVRLIVARGRLMQRATGTGRMVNVEASAEDVRATLDERHPEVCVATVNGPRSVVVAGPGEAVDKAVAELRAGGASTIALPVDYAFHSPLMRPYGDELESLLGSLRPAEPGVRMVSTVAPDEPLPALDAQYWGRNLREPVLFWPAVDQVLAEGDADFVEIGAHPVLGRPLQSAITERGRGGAVVGSLTRDKAAHTTLAHARARLHTAGVAVDWAALLRGPVRPAALPPHRWADERHWLSGVHRGQQSSGGFSAEGLSAQVRLFDAAGTLVGEIDAGAVATTATPRGTGANGTPVNGAAPNGTGPLSATPTVAPQAAAPAGPAAAPDQQAAVTAPWDREQLAAAVQGALATVLGHAPGKRLPVTRGFFELGIDSISVAELARQVEEAVGVPLDGADVLSHASVEALTDYLVTLDPPPRNAPGRRQAPDQPAGDAPAPEAGPQVTPRQDSGGVSERPAADVRTVEPAAPAAPAPADQPPAGPEPIAIVGIGCRLPGGADGPQAFWRLLSDRTDTTGPVPADRWNAAELLARGKVTPGTVATARGAFLDGVDGFDHGFFRVSPREARSMDPQQRLFLEVAWESLEDAGIRTELLRGGRTGVFVGLNTTDYQQLVTRDHNDVDLYYGTGNSFCGTAGRLSYFLGVRGPSIAVDTACSSSLTAIHLACQSLRAGESDLAVAGGANVMSTPTVFLAMSAAGALAPDGRCKTFDDSADGYGRGEGAGALVLKTLSRAVRDGDRVYAVIRGSAVNQDGASGGLTVPSGEAQEEVIRAALEQAGVPAEHVDYVEAHGTGTRLGDAIELRALAGALGSGRAPDRPLLVGSVKTNVGHLEAAAGVTGLIKTVLALNHQEIPAHLHVKTPTRQVAWDRLPVRVVTDATAWPRGDRPRLAGISAFGFTGTNAHVVVEEPPAPVGRPAPQPGTGRPLVLTVTAVSAVALRATAGRWGERVAAARDDELADLCWASGARRTHHEHRVAVVATTRRELADALAAVARSDTADGVVLGTGRPGEYRRLGFLYGDTVPDLPWAELLGAASPGSGDGGTARTLLGGSDAAAAFRAEVVDVDAALRDALGFSPVRAWETGTLPEPGSTQHEALVLAGQLTGTALWSRLGMTPDTVAGHGVGEYAAAVAAVELTATEAVHRFAAGRGVGEPGGPGVLTRHAASAGWPAIGGLLAQDGVEVLLALGVGEPEAERVSAAFAGNGSEVRVLRLRGRGLDPLRTAAELQVHGCRVDWDGLLPQAHRMVTLPTYPWQRRSHWITPLAPAADPVTAPATTAPTDGGPLPSVNGAAPEATAPVPAPPVAAPPVPAGPPVSAQGAPGAADRPEDAAGRPVTPLVAELTALPAEARAERLLTTLLDLVAEVLGGADDVAPEQGFFELGVDSVLGAELKERAEDQLGRELPGTIMFECPNALSFAEFILDDLFGGAEPETGPPAAPGNAAPRPDGAGAAGTAASAGDGAVSGAEDVAEGDDGLDDLSDDALMGRLLSALSSSEALLTEGD	MRDTRFPCLCGIAASTLLFATTPAIADEAPADRLKALVDAAVQPVMKANDIPGLAVAISLKGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWPALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNPSIGLFGYLAARSLGQPFERLMEQQLFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVGPGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEAYDWPISLKRLQAGNSTPMALPPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRDLGLVILANRNYPNAERVKIAYAILSGLEQQAKVPLKR	545.84	gnl|BL_ORD_ID|4433|hsp_num:0	5503			780	978	
BGC0000130.1|Pyrrolomycin_20 # 33254 # 34162 # 1 # ID=1_20;partial=00;start_type=ATG;rbs_motif=GGGGA;rbs_spacer=3bp;gc_cont=0.723	BGC0000130.1|Pyrrolomycin_20 	33254	34162	+	Loose	500	26.9498	ErmD	25.0	3000495	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; streptogramin B antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGAATTCGTACGTGAGATCGCTCGCCACCGTTACTCAAGCCGCTTGCGCCGCACTAGAGGCAGTGGGGAAGGCCCCCAGGCGGGGCAAGGAACCAGACCCGGAGGGCCCGTTGACCACACCTGTCTCCCCCGATCCCGGCGCGACCAGGGACGACGCCAACTCACTCACGCTGTACTGCCTGGCCCACGCGGGCGGCAGCGCCATCCCCTACACGCGGTGGAACCGGTTCCTGCCGGCCGGTGTCAGGGTCGAACCCCTGGAACTCCCGGGCCACGGCGCGCGGCTGCGCGAGCCGCTGCTCGAGCAGGTGGAGCCCATCGTGGCGGACCTGTTGCGCACCGTGGGGCCGCGCCGGGGAGCGCCGTTCGCACTCTTCGGTCACAGTTTCGGCGCGGTACTCGCGTTCGAGTTGACCCGCCGGCTGGTCCGCCTCGGCACTCCGCCCGCCGCCCTCCTGGTCGCCGGGCGCAACGGCCCGACCCAGCCGCTGGCCCACCGCCCGATCCACAACCTGGACGACGAGGCGTTCGTCGCGGCGCTCATCCGGTTCGGCGGCATGCCGCAGGCCCTGTTGGAGCAGCCGGAACTGCTGCGGATCTACCTGCCGGTGCTGCGGGTGGACCTACGGCTCGCCGAAACCCATCCGCGCCCGCCGGGGCCGCCGTTCGACGTGCCGGTGACGGCCTTCGGCGGCCGGCGGGACGTGCTCGCCGACCCGGAGGGCCTGTTGACCTGGGAGCGGGAGACCACCGGGGAGTTCGAGCTCGCCCTGCTTCCCGGCGGTCACTTCTTCCTCGACGAACCGGCGTTCCACTCCCTGCTGCTGTCCCGGCTGGCCCGCCTGACCCCACGGGCCACCGGGAACGATCCGCTCAGCCGCGGAACGACACCGGCAGCGCGCCGGTGA	MNSYVRSLATVTQAACAALEAVGKAPRRGKEPDPEGPLTTPVSPDPGATRDDANSLTLYCLAHAGGSAIPYTRWNRFLPAGVRVEPLELPGHGARLREPLLEQVEPIVADLLRTVGPRRGAPFALFGHSFGAVLAFELTRRLVRLGTPPAALLVAGRNGPTQPLAHRPIHNLDDEAFVAALIRFGGMPQALLEQPELLRIYLPVLRVDLRLAETHPRPPGPPFDVPVTAFGGRRDVLADPEGLLTWERETTGEFELALLPGGHFFLDEPAFHSLLLSRLARLTPRATGNDPLSRGTTPAARR	MKKKNHKYRGKKLNRGESPNFSGQHLMHNKKLIEEIVDRANISIDDTVLELGAGKGALTTVLSQKAGKVLAVENDSKFVDILTRKTAQHSNTKIIHQDIMKIHLPKEKFVVVSNIPYAITTPIMKMLLNNPASGFQKGIIVMEKGAAKRFTSKFIKNSYVLAWRMWFDIGIVREISKEHFSPPPKVDSAMVRITRKKDAPLSHKHYIAFRGLAEYALKEPNIPLCVRLRGIFTPRQMKHLRKSLKINNEKTVGTLTENQWAVIFNTMTQYVMHHKWPRANKRKPGEI	105.23	gnl|BL_ORD_ID|1022|hsp_num:0	1117			81	261	erythromycin; roxithromycin; lincomycin; telithromycin; clarithromycin; clindamycin; tylosin; spiramycin; azithromycin; dirithromycin; pristinamycin IA; quinupristin; virginiamycin M1; madumycin II; griseoviridin; dalfopristin; pristinamycin IB; virginiamycin S2; pristinamycin IC; vernamycin C; patricin A; patricin B; ostreogrycin B3; oleandomycin
BGC0000130.1|Pyrrolomycin_21 # 34128 # 34778 # -1 # ID=1_21;partial=00;start_type=TTG;rbs_motif=AGCGG;rbs_spacer=11bp;gc_cont=0.714	BGC0000130.1|Pyrrolomycin_21 	34128	34778	-	Loose	400	55.0694	MexL	44.93	3003710	protein homolog model	n/a	n/a	macrolide antibiotic; tetracycline antibiotic; disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	TTGAGCGACGGTGCGGGGGAGGAGGAACTGACGCGCACCGCGCGGAAGCGGACCGGGCGTCGTCCGGGCAACACCGAGAGCAGGCAGCTCATCCTGGACGCGGCGCGCGCCAAGTTCGCCACCCATGGCTACGAGGGCGCCTCCATCCGGTCCATCGCCCAGGAGGCCGGGGTGGACACCGCCCTGATCCACCACTTCTTCACGTCCAAGGACGGCTTGTTCTCCGCCGCGGTGCACGACGCGGTCCACCCGGAGCAGCTCGTCGCCGCGGTGGTGGGGAAGCGGCGGGCGCTGCGCGGGCTCGGGGAACGGATGGTCCGGGCCATCGTCGGGCTCTGGGAGGGCGAGGTCAGCCGGAACCAGATGAGCAGCATCATGCGCTCGGCGGTGTCCCACGAGGTGGCAGCGCAACTGCTCCGCCGGTTCTTCACCGAGGAGGTCGCGCTGCCCGTCGCGCGGTCCACCGGCAAGTCCGACCCCGAGGTGCGCGCCGCGCTGGTCACCTCGCAGTTGGTCGGCCTGGCCATGACCCGGTACATCGTGCAGGTGCACCCGATCGACAAGCTGCCCGCCGACGAGCTGGTGGCGTGCATCGCGCCGACGATCCAGCGCTACCTCACCGGCGCGCTGCCGGTGTCGTTCCGCGGCTGA	MSDGAGEEELTRTARKRTGRRPGNTESRQLILDAARAKFATHGYEGASIRSIAQEAGVDTALIHHFFTSKDGLFSAAVHDAVHPEQLVAAVVGKRRALRGLGERMVRAIVGLWEGEVSRNQMSSIMRSAVSHEVAAQLLRRFFTEEVALPVARSTGKSDPEVRAALVTSQLVGLAMTRYIVQVHPIDKLPADELVACIAPTIQRYLTGALPVSFRG	MSESTSSVGPGRPKDPAKREAILEAAKRLFLCNGYDGSSMEAIASEAGVSKLTVYSHFTDKETLFSEAVKAKCAEQLPALYFQLAEGAPLEKVLLNIARGFHRLINSHEAIALTRLMAAQAGQNPKLSELFFEAGPKQVIDEMERLLEQARRSGKLAFPDARHAAEHFFMLVKGCANYRLLIGCAEPLDEAEGERHVEEVVALFLRAFAAGG	101.89	gnl|BL_ORD_ID|4690|hsp_num:0	2219			33	237	erythromycin; tetracycline; triclosan
BGC0000130.1|Pyrrolomycin_22 # 35100 # 35372 # 1 # ID=1_22;partial=00;start_type=ATG;rbs_motif=GGGAGG;rbs_spacer=5bp;gc_cont=0.593	BGC0000130.1|Pyrrolomycin_22 	35100	35372	+	Loose	400	25.409	ErmE	56.25	3000326	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; streptogramin B antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGACGGCCATCAGCCGCGATGAGATCTACACGAAACTCAGCGCCTACATACAGGAACAGTTCCTGGACGACAGCGAGATCTCGGAGCTGAAGCCGGACACCCCACTGCTGGAGTGGGGCGTGCTGAACTCCATGAACACCTCGATCCTGCTCACGTACATCAGGACCGACCTCGGGGTCACCGTTCCCCCGACGCACATCACCGGTCGGCACTTCTACAGCCTCGACACCATCACCGACATGGTCTACGAGCTGTCTCTTCAGCCTGCGTGA	MTAISRDEIYTKLSAYIQEQFLDDSEISELKPDTPLLEWGVLNSMNTSILLTYIRTDLGVTVPPTHITGRHFYSLDTITDMVYELSLQPA	MSSSDEQPRPRRRNQDRQHPNQNRPVLGRTERDRNRRQFGQNFLRDRKTIARIAETAELRPDLPVLEAGPGEGLLTRELADRARQVTSYEIDPRLAKSLREKLSGHPNIEVVNADFLTAEPPPEPFAFVGAIPYGITSAIVDWCLEAPTIETATMVTQLEFARKRTGDYGRWSRLTVMTWPLFEWEFVEKVDRRLFKPVPKVDSAIMRLRRRAEPLLEGAALERYESMVELCFTGVGGNIQASLLRKYPRRRVEAALDHAGVGGGAVVAYVRPEQWLRLFERLDQKNEPRGGQPQRGRRTGGRDHGDRRTGGQDRGDRRTGGRDHRDRQASGHGDRRSSGRNRDDGRTGEREQGDQGGRRGPSGGGRTGGRPGRRGGPGQR	23.62	gnl|BL_ORD_ID|94|hsp_num:0	109			159	207	erythromycin; roxithromycin; lincomycin; telithromycin; clarithromycin; clindamycin; tylosin; spiramycin; azithromycin; dirithromycin; pristinamycin IA; quinupristin; virginiamycin M1; madumycin II; griseoviridin; dalfopristin; pristinamycin IB; virginiamycin S2; pristinamycin IC; vernamycin C; patricin A; patricin B; ostreogrycin B3; oleandomycin
BGC0000130.1|Pyrrolomycin_23 # 35616 # 36779 # 1 # ID=1_23;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=9bp;gc_cont=0.649	BGC0000130.1|Pyrrolomycin_23 	35616	36779	+	Loose	600	27.7202	OprZ	32.0	3004142	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; cephalosporin	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCCCAAGGTGGAGGCGGCGAACTTCCCCAAGAAGTTCGGTGCCGCCTGGACCTCGGCCGAAGACCGGAACATCGACCACAACGGCTTCCGCGGACTCACCCACGACTTCCGCGCCGCTGAGATCCTGTTCAACGAGCGCGACCAGGACGGTGTGGACCGCGACTACACCTTCCACGTGGACCGGGGCAAGTTCGACCAGATCCTCCTCCAGCACGCGGAGAGCCTCGGGGCCAAGGTGTTCCACGGCATCCGCATCGGCAAGGTGGACTTCGACGGCGAGATGCCGGTGCTCGAGGCCAAGATCGGCAGCAAGTCGGTCGACATCCCGGTCCGCATGGTCGTGGACGCCAGCGGCCGGCAGACCCGCCTCGGCAACCAGCTCAAGTTCAAGGTCCCGGACCCGATCTTCAACCAGTACGCGGTCCACTCGTGGTTCGACAACTTCGACCGCAAGGCCCTGGCGGTCAACAAGGACCAGGCGGACTACATCTTCATCCACTTCCTGCCGGTCACCGACACCTGGGTGTGGCAGATCCCCATCACCGACACCATCACCTCGATCGGTGTGGTCAGCCAGAAGAAGCGGTTCCAGGAGTTCGCCGGGGACCGGGAGAAGTTCTTCTGGGACACCGTCGCCAGCCGCCCCGAACTGCTCGACGCCCTGAAGAACTCGGACCAGGTCCGGCCCTTCAAGACCGAGGGTGACTACAGCTACGGCATGTCGCAGATCGCGGGCGACAACTTCGTCCTCATCGGCGACGCGGCCCGCTTCGTGGACCCGATCTTCTCCAGCGGTGTGTCCGTGGCGCTCAACAGCGCCCGCCTCGCCTGCAAGGACATCATCGCCGCCGCCGAGGCGGGCGACTTCAAGAAGGAGCGCTTCGGGACCTACGAGCGCAAGCTGCGCAAGGGCGTCTCGAACTGGTACGAGTTCATCCAGATCTACTACCGGCTCAACATCCTGTTCACCGCGTTCGTCCAGGACGACCGGTACCGCCTGGACGTGCTGAAGATGCTCCAGGGCGACGTCTACGACGACGAGGAGCCCAAGGCCCTCGCCGCCATGCGGGAGATCGTCAAGGCGGTGGAGGACGACCCCACCCACCTGTGGCACCCGTACCTCGGCAGCCTCAAGGCCCCGTCGGCGAAGCCCCAGTTCTGA	MPKVEAANFPKKFGAAWTSAEDRNIDHNGFRGLTHDFRAAEILFNERDQDGVDRDYTFHVDRGKFDQILLQHAESLGAKVFHGIRIGKVDFDGEMPVLEAKIGSKSVDIPVRMVVDASGRQTRLGNQLKFKVPDPIFNQYAVHSWFDNFDRKALAVNKDQADYIFIHFLPVTDTWVWQIPITDTITSIGVVSQKKRFQEFAGDREKFFWDTVASRPELLDALKNSDQVRPFKTEGDYSYGMSQIAGDNFVLIGDAARFVDPIFSSGVSVALNSARLACKDIIAAAEAGDFKKERFGTYERKLRKGVSNWYEFIQIYYRLNILFTAFVQDDRYRLDVLKMLQGDVYDDEEPKALAAMREIVKAVEDDPTHLWHPYLGSLKAPSAKPQF	MKPVAMTLLALALSGCSLAPTHERPAAPVPAQYDTPAQPGQAAAPQDWRAYFNDPALQAWIAAALANNRDLRVAALRIEEARALYGVQQSERLPAIDASGEFSRGRATEPGQPRTPVSNRYRAAVGITAFELDFFGRVRSLSDAALARYLASEEAHRAATLALVAETATAYFNQRSLAEQLRLTDDTLALRETTLKLTQRRYDAGLETAIGLRTAQMLVESSRATRAELTREASLARHALGLLAGDFALPLGVDPTPLESQSLTPLAAGLPSELLTRRPDLRQAEQALRAANADIGAARAAFFPSVQLTTDIGTTADRFSDLFSGGTGGWSFAPRLTLPIFNAGRNRANLSLAETRKHIAVAQYEGSIQAAFRDVADALSARDALRDQIEAQRKVRDADRERQRLAERRYARGVANYLEMLEAQRSLFESEQEFIRLQQRRLVNAVDLYKALGGWDDGSSPAS	83.59	gnl|BL_ORD_ID|2408|hsp_num:0	2796			1137	1362	erythromycin; cefepime
BGC0000130.1|Pyrrolomycin_24 # 37053 # 37946 # -1 # ID=1_24;partial=00;start_type=ATG;rbs_motif=AGGGG;rbs_spacer=5bp;gc_cont=0.733	BGC0000130.1|Pyrrolomycin_24 	37053	37946	-	Loose	700	26.1794	ADC-173	31.58	3006345	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	ADC beta-lactamases pending classification for carbapenemase activity	ATGGCCAGCACGCGCGCCGTCATCCATCCGTTCGGCAACCCACCCGCCCAGCAACCGGCGGTGGCGGAGCCGGTGCGGGTGCGCGGGACCGCGGGGCCGTGGGACCGGGTCCGACACGACCTGGCCTCGCTGGGTTGGGCGGTGCTGCACGCGCGGATCGACGACTGGCTGCCGCACCCCGCGCACACGCCCTCCCTGAAGCGGCTGCTGGGCCGGGACTGGGAGCGCTACCTGCGGATGCGCAACCCCAGGGTCCGGGCCCGGTTCGCCGCCACCCGCTCCCTGCTCAAGCACGCCGCGGGCGTCGCCGTCCAGGCGCCCCCGCACACCGTGGAGCTGGCCTACACCGCGTTCGGCCGTCCCTATCTGCGCGGCCTCGACCAGGTGGACGTCAGCCTCAGCCACACCGGTGACTTCCTGCTGGTGGGGCTGACGACCCGGGGCCGCATCGGGGTGGACGCGGAGAAGATCGACCGCCCGCTGCTGCGCAACGGCACCGAGCGGCACATCTGCACCCCGTACGAGCTGGACATGCTGGAACGGGTCCCCGAGGCCCGGCGGAACCGCAGCGCGGTGCGGCTGTGGACGCTCAAGGAGGCGTACAGCAAGGCCATCGGGCAGGGTCTGCGGTTCCGTTTCTCCGAGTTCGGGTTCGGGGAGGACGGACAACCGGTGCGGGTGCAGCGTCCGGACGGCACCCCGGGCACCGGAAGCGAGTGGACGTTCGCCACGTTCACGCCCGACCAGCAGTACTGCGCCAGCGTGGCGGTCCACGACACGGGGTTCGGCGCCCCGGCTGACACCGCCGCGGCGACGATGCTGGACTCGGGCCTGGTGGACGCGGTCAACGAGTTGGTCGCCCGGGCCAGGAGCGAGCAGCGGGCCGCGGCCTGA	MASTRAVIHPFGNPPAQQPAVAEPVRVRGTAGPWDRVRHDLASLGWAVLHARIDDWLPHPAHTPSLKRLLGRDWERYLRMRNPRVRARFAATRSLLKHAAGVAVQAPPHTVELAYTAFGRPYLRGLDQVDVSLSHTGDFLLVGLTTRGRIGVDAEKIDRPLLRNGTERHICTPYELDMLERVPEARRNRSAVRLWTLKEAYSKAIGQGLRFRFSEFGFGEDGQPVRVQRPDGTPGTGSEWTFATFTPDQQYCASVAVHDTGFGAPADTAAATMLDSGLVDAVNELVARARSEQRAAA	MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNNKKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKELKNTPIDQVNLLQLATYTSGNLALQFPDEVKTDQQVLTFFKDWKPKNSIGEYRQYSNPSIGLFGKVVALSMNKPIDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNRGPLDAAPAYGVKSTLPDMLSFIHANLNPQKYPADIQRAINETHQGRYQVNTMYQALGWEEFSYPATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTNGFGTYVVFIPKENIGLVMLTNKRIPNEERIKAAYAVLNAIKK	77.34	gnl|BL_ORD_ID|3188|hsp_num:0	4241			672	840	
BGC0000130.1|Pyrrolomycin_26 # 40225 # 41607 # 1 # ID=1_26;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=8bp;gc_cont=0.719	BGC0000130.1|Pyrrolomycin_26 	40225	41607	+	Loose	600	27.335	SGM-1	39.47	3006987	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	SGM beta-lactamase	ATGAGCAGCCCCAGCACAGCAGCAGAGCAGGCCGGCACGCCCGCCGCGGGCCTCGACTACTCGCCGGGCTTCGGGAACGAGCACGTCAGTGAGGCAGTGCCGGGAGCGTTGCCGGTCGGGCGGAACTCCCCGCAGCGCGCACCGCTCGGCCTGTACGCCGAGCAGTTGAGCGGTACGGCCTTCACCGAGCCCCGGCACGCCAACCGCAGGAGCTGGCTGTACCGCATCCGCCCCTCCGCCGCGCACCCGAGGTTCCGCAGGACCGACAACGGTGCCCTGCTCAGCGCGCCGTTCACCGACAGCGAGCCCGACCCGAACCGGCTGCGCTGGGACCCGCTGCCGCTGCCCGAGCGGGACACCGACTTCGTCACCGGGCTGTACACCGTCGGGGGCAACGGCGACGTGCTGCGCCGCTGCGGCATCGGCATCCACCTGTACCGCGCCAACCGCTCCATGGTGGACCGGGTGTTCGTGGACTCCGACGGGGAGCTGCTGATCGTCCCGGAGCTGGGCGGGCTGCTGGTGCGCACCGAGCTGGGGCTGCTCGAGGCACGGCCCGGGCAGGTGGCACTGGTGCCCCGCGGGGTGCGGTTCCGGGTGGAGCTGCTCGACGGGGCGGCGCGGGGCTACGTCTGTGAGAACTACGGTCAGCCGTTCCGGCTCCCCGACCTGGGGCCGATCGGTGCGAACGGCCTGGCCAACCCCCGGGACTTCCTGGCGCCCGTGGCGGCCTTCGAGGACGTCGAGGAGCCGGTGGAGGTGGTGAACAAGTTCGGTGGGAACCTCTGGGCCGCCCAGTACGACCACTCACCGCTCGACGTGGTCGCCTGGCACGGCAACTACGCCCCCTACGTCTACGACCTGTCCAGGTTCAACGTCCTCGGCTCGATCAGCTTCGACCACCCGGACCCGTCGATCTTCACCGTGCTGACCTCGCCGTCCAGCACGCCCGGCCTGGCCAACGCCGACTTCGTGGTCTTCGCGCCCCGTTGGCTGGTCGGCGAGGACACCTTCCGGCCGGCGTACTTCCACCGCAACGTGATGAGCGAGTTCATGGGTCTGATCGACGGCGCCTACGACGCCAAGGCCAGCGGGTTCGCGCCGGGCGGGGCCAGCCTGCACAACATGATGAGCGCGCACGGGCCCGACCGGGACACCTACGCCAAGGCCAGCAGCGCCGAGCTGCTGCCGGAGAAGGTGGACGGGGGCACGGCCTTCATGTTCGAGACCCGCTGGCCGGTGGTGGTCACCGCGCAGGCGATGGCGGCGGACCACCGGCAGCAGGACTACGACGCCGTCTGGCGGGACATCGGTCGGGGCTTCCCCGGGACGGCGCCGGCCGACGGGCCCGTCCGGTCGGCGGGGCCGGAGCGGACCAGGTGA	MSSPSTAAEQAGTPAAGLDYSPGFGNEHVSEAVPGALPVGRNSPQRAPLGLYAEQLSGTAFTEPRHANRRSWLYRIRPSAAHPRFRRTDNGALLSAPFTDSEPDPNRLRWDPLPLPERDTDFVTGLYTVGGNGDVLRRCGIGIHLYRANRSMVDRVFVDSDGELLIVPELGGLLVRTELGLLEARPGQVALVPRGVRFRVELLDGAARGYVCENYGQPFRLPDLGPIGANGLANPRDFLAPVAAFEDVEEPVEVVNKFGGNLWAAQYDHSPLDVVAWHGNYAPYVYDLSRFNVLGSISFDHPDPSIFTVLTSPSSTPGLANADFVVFAPRWLVGEDTFRPAYFHRNVMSEFMGLIDGAYDAKASGFAPGGASLHNMMSAHGPDRDTYAKASSAELLPEKVDGGTAFMFETRWPVVVTAQAMAADHRQQDYDAVWRDIGRGFPGTAPADGPVRSAGPERTR	MKIVTALGALALLAAPASAADRQKTPAQEPAPTGNLDNLMPAAPRYLVPQSALEQVRNPKEIEEETGGRLGVALVDRQGALLLGFNRDERFAMCSTFKAPLAAAVLTGADGGKFGLEGTIPFGKEDVLDYAPVVKKNLKRGRMSMEELARAAVEVSDNSAANLLLPMLGGPEGLTAFMRVHGDDVTRLDRTEPALNENAEGDPRDTTTPAAMAGLMARLFFRDLKAESADRLRAWFNASSTGDKRIKAGLPEGWTSGSKTGSCGTAYNDVALVKSPTGEEYILAIYLDRPTIDAKKAEAAIAEAARAALNFVGQARKSGLE	143.30	gnl|BL_ORD_ID|4574|hsp_num:0	5644			123	234	
BGC0000130.1|Pyrrolomycin_27 # 41604 # 42356 # 1 # ID=1_27;partial=00;start_type=GTG;rbs_motif=AGCGG;rbs_spacer=5bp;gc_cont=0.733	BGC0000130.1|Pyrrolomycin_27 	41604	42356	+	Loose	300	28.4906	dfrA22	27.45	3003018	protein homolog model	n/a	n/a	diaminopyrimidine antibiotic	antibiotic target replacement	trimethoprim resistant dihydrofolate reductase dfr	GTGACCGACGGCACCCACCAGCCGGCCCCGATCACCCTGAACCGCAGGTTGCCCCTGTGGTACCAGGTCTCGCAGAGCCTACGGGCCTCCGTCCTCGGCCGCGGCCCGGACAGCCCGCTGCGGCTGCCGACCGAGGAGGACCTCGCCCGGCACTACGGCGTCAGCGTGCTCACCGTGCGCCAGGCGTTGAAGCCGTTGGAGGAGGAGGGCCTGATCACCCGGCACCGGCGGCGGGGCACCTTCATCGACCCCGCCGCCCGCCCCATGGCACCGATACGGCTGCTGGGTTCCGTGGACGCCATCGTGGCCCAGCAGTCGAGTGAGGAGGCGACGGTGCTGGGCCGGGGCACCGCCGCGGCCCCCGCCGACCTGGCCGAGCACTTCCCGCCGGGCTCCGGGACGGCGTGGTTCCGACGGCTGCGCCGCCACGGCGGGGAGCCGTCGAGCTGGGCGGAGAACCACGTGCTGCCCGAGCTCGGGGAGCGGGTGCGCACCGAGGACCTGGAACGCTGGCCGATGACCAGGGTGCTGCGGGACCGGCTCGGGGTGCGGATCAGCCGGATCACCGACACCGTGCAGGCCCGGCTCGCCGACCCGGAGACGGCCGAGCTGCTGGGGGTGCCCCTGCTCAGCCCGATCCTGCACTACACCGGGGTGACCTACGACCACGAGAACCAGGTGGTGGACGTGGCGCGCATCCACTACCGGGGAGACCGCTTCTCGTTCTCGGTGACCCTGGAGGCGGAGTCCTGA	MTDGTHQPAPITLNRRLPLWYQVSQSLRASVLGRGPDSPLRLPTEEDLARHYGVSVLTVRQALKPLEEEGLITRHRRRGTFIDPAARPMAPIRLLGSVDAIVAQQSSEEATVLGRGTAAAPADLAEHFPPGSGTAWFRRLRRHGGEPSSWAENHVLPELGERVRTEDLERWPMTRVLRDRLGVRISRITDTVQARLADPETAELLGVPLLSPILHYTGVTYDHENQVVDVARIHYRGDRFSFSVTLEAES	MNRESVRIYLVAAMGANRVIGNGPDIPWTIPGEQKIFRRLTEGKVVVMGRKTFESIGKPLPSRRTVVLSRQAGYSAAGCAVVSTLSQAIAIAAEHGKELYVAGGAEVYALALPHADGVFLSEVHQTFEGDAFFPVLNAAEFEVVSAETVQATITYTHSVYARRNG	151.52	gnl|BL_ORD_ID|1243|hsp_num:0	1356			0	294	trimethoprim
BGC0000130.1|Pyrrolomycin_28 # 42449 # 43600 # 1 # ID=1_28;partial=00;start_type=GTG;rbs_motif=AGGAGA;rbs_spacer=4bp;gc_cont=0.704	BGC0000130.1|Pyrrolomycin_28 	42449	43600	+	Loose	150	28.8758	nimB	38.71	3004655	protein homolog model	n/a	n/a	nitroimidazole antibiotic	antibiotic inactivation	nitroimidazole reductase	GTGCGCCGCACCGTGTTCAACGATGACCACGAGGCATTCCGGGAGACCGTCCGGGCGTTCCTCACCAAGGAGGTCGTCCCGCAGTACGCGCAGTGGGAGCAGCTCGGCCACCCTCCCCGTGAGTTCTACCGACGGATGGGCGCGCTGGGGCTCCTGGGCATCGCGGTCCCCGAGGAGTTCGGCGGTGGCGGGGCCAGCGGGCTGAGGTTCAGCGCCGTGCTCTCCGAGGAGACCGCCCGGCACGGAGTCACCCTGGGCGCCAGCCGGGTCCACTCCGACCTGGTCCTGCCGTACCTGTTGGAGTACGCCACCCCCGAGCAGAAGCAGCGGTGGCTGCCGGGCTTCGCCAGCGGCGACCTGATGACCGCGATCGCCATGACGGAGCCGGGGACCGGGTCCGACCTGGCCGGGATCACCACCACCGCCCGCCGGGACGGCGACGTCTACGTGCTCAACGGCTCCAAGACGTTCATCACCGGCGGGGCCCTCGCCGACCTGGTGCTGGTGGTCTGCCGCACCGCCCCGCGGCAGGACGGCGACCGTCGGGCCGGGCTGAGCATCCTGGTGGTGGAGGCCACGTCCCCGGGTTTCAGCGTCGGCCGGAAGCTGGAGAAGATCGGCTTGCGCACCCAGGACACCGCGGAGCTGTTCTTCGACGAGGTGCGGGTGCCCGCGGCCAACCTCCTGGGCGAGGAGGGCGAGGCGTTCGGCTACCTCTCCCACAACCTGGTGCAGGAACGACTCGCCATCGTCATCGGAGCGGTGACCGCCGCCGCGGCGGCGGTGGAGATGACCGTGGAGTACGTCCGCCAGCGCGAGGTGTTCGGCAAGCCGCTGTCCTCGTTCCAGAACACCAAGTTCGTGCTCGCCGAGTGCGCCGCCGAGGTGGAGGCCGGTCAGGTGCTGATGGACCGGGCGATCGAGGAGCACGAGCGCGGGGAGCTGAGCCACGCGGACGTGGCCAAGGCCAAGCTGTTCTGCACCGAGATGGAGGGCCGCGTGATCGACAAGTGCCTCCAGCTCCACGGGGGGTACGGCTACATGCTCGAGTACCCGATCGCCCGGCTGTACGCCGACGCCCGGGTGCACCGGGTGTACGGCGGGACCAGCGAGGTGCAGAAGTCCATCGTCGGCAAGTCGCTGGGCCTGTGA	MRRTVFNDDHEAFRETVRAFLTKEVVPQYAQWEQLGHPPREFYRRMGALGLLGIAVPEEFGGGGASGLRFSAVLSEETARHGVTLGASRVHSDLVLPYLLEYATPEQKQRWLPGFASGDLMTAIAMTEPGTGSDLAGITTTARRDGDVYVLNGSKTFITGGALADLVLVVCRTAPRQDGDRRAGLSILVVEATSPGFSVGRKLEKIGLRTQDTAELFFDEVRVPAANLLGEEGEAFGYLSHNLVQERLAIVIGAVTAAAAAVEMTVEYVRQREVFGKPLSSFQNTKFVLAECAAEVEAGQVLMDRAIEEHERGELSHADVAKAKLFCTEMEGRVIDKCLQLHGGYGYMLEYPIARLYADARVHRVYGGTSEVQKSIVGKSLGL	MFREMRRKRQLLPTEESVAILERMTNGTLALHGDDGYPYAVPISYVYADGKIYFHSAMKGHKVDAILQNDKVSFCVVEQDDIRPSEFTTYFRSVIVFGKAHILTDELEKRVALGLLADKYSYGEAGMEAEIAKGFNHLLIVKIAIEHITGKEAIELTKNRNDRP	233.54	gnl|BL_ORD_ID|4791|hsp_num:0	5787			66	159	metronidazole
BGC0000130.1|Pyrrolomycin_29 # 43600 # 44763 # 1 # ID=1_29;partial=00;start_type=ATG;rbs_motif=GGG;rbs_spacer=6bp;gc_cont=0.747	BGC0000130.1|Pyrrolomycin_29 	43600	44763	+	Loose	1800	25.7942	MexD	30.14	3000801	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; cephalosporin; penam; tetracycline antibiotic; aminocoumarin antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGGCACCGACACCGAAGGGGCCCCGGGCCGGGGGGGCCCGCTCGCCGGGGTGCGGGTGCTGGAACTCGGCGGCATCGGCCCGGGACCGTTCTGCGGCATGGTCCTCGCCGACATGGGCGCCGACGTCATCAGGGTGGAGCGCCCCGGGGACCGCGGCGCGCTGGCCATGCCGGTGCTGCTGCGGGGACGCCGTTCCGTCGCCCTGGACCTGAAGGACCCCGTCGCGGCACGAGCGGTCCGCAGCATCGCCGAGCGCTGCGACGCGCTGATCGAGGGGTTCCGGCCGGGGGTGACCGAGCGGCTCGGGCTCGGGCCGGAGGAGCTGTGCCAGGCCAACCCCCGCCTGGTGTACGCCCGGATGACCGGCTGGGGGCAGGACGGCCCGCACGCCCAGGCGCCCGGTCACGACATCAACTACCTGGCGCTCTCGGGGGCGCTGCACACCTTCGGCCCCGCGGACGGTGACCCCGTTCCCCCGTTGAACCTGGTCGCCGACTTCGGCGGCGGAGGCATGCTGCTCGCCCTCGGCGTGGTCAGCGCCCTGCTCCGGGCCCAGCGTGACGGCCGGGGCCAGGTGGTGGACGCCTCCATGGTGGACGGGACCGCCCTGCTGCTCGCCATGACCTACGGCTTCCTCGCCAACGGGCTGTGGACCGACCAGCGCGGGGTCAACCTGCTCGACGGCAGCGGCCCCTTCTACCGGGTCTACCGGTGCCGTGACCAGCGCCACGTGGCGGTGGGCTGCCTCGAGGAGCAGTTCCGCGCCGACCTGCTGCGGGTCCTCGGCCTCACCGACGACCCGGACTTCGCGACCCCGGACGACCGGAAGAACTGGCCGGTGATGAACCAGCGCCTGGAGCAGATCTTCACCAGCCGCACCCGCGACAACTGGGCCGCCCTGTTCGAGGGCACCCAGGCGTGCGTCACCCCGGTGCTGTCCCTGAACGAGGCCGCGGCGCACCCGCACAACCTCGCGCGCGGCACCTACCTCGCCGGCCCCACCGGGATCGTCCAACCCAGCCCCGCGCCGCGGTTCGGGGGGACGCCGAGCGACGCGCCGAGGGCCGCGCCCACACCCGGCGAACACACCGCGGAGGTGCTGGCCGAAGCGGGGCTCACCAGTGCGGAGATCGCTGCCCTGACCCCGGAGCCGGGCCGGTGA	MGTDTEGAPGRGGPLAGVRVLELGGIGPGPFCGMVLADMGADVIRVERPGDRGALAMPVLLRGRRSVALDLKDPVAARAVRSIAERCDALIEGFRPGVTERLGLGPEELCQANPRLVYARMTGWGQDGPHAQAPGHDINYLALSGALHTFGPADGDPVPPLNLVADFGGGGMLLALGVVSALLRAQRDGRGQVVDASMVDGTALLLAMTYGFLANGLWTDQRGVNLLDGSGPFYRVYRCRDQRHVAVGCLEEQFRADLLRVLGLTDDPDFATPDDRKNWPVMNQRLEQIFTSRTRDNWAALFEGTQACVTPVLSLNEAAAHPHNLARGTYLAGPTGIVQPSPAPRFGGTPSDAPRAAPTPGEHTAEVLAEAGLTSAEIAALTPEPGR	MSEFFIKRPNFAWVVALFISLGGLLVISKLPVAQYPNVAPPQITITATYPGASAKVLVDSVTSVLEESLNGAKGLLYFESTNNSNGTAEIVVTFEPGTDPDLAQVDVQNRLKKAEARMPQAVLTQGLQVEQTSAGFLLIYALSYKEGAQRSDTTALGDYAARNINNELRRLPGVGKLQFFSSEAAMRVWIDPQKLVGFGLSIDDVSNAIRGQNVQVPAGAFGSAPGSSAQELTATLAVKGTLDDPQEFGQVVLRANEDGSLVPARRCRAPGTRQGELQHFLATERHAHRGRGYPAVARGQRDPDPTLVKQRLAELSAFFPEDMQYSVPYDTSRFVDVAIEKVIHTLIEAMVLVFLVMFLFLENVRYTLIPSIVVPVCLLGTLMVMYLLGFSVNMMTMFGMVLAIGILVDDAIVVVENVERIMAEEGISPAEATVKAMKQVSGAIVGITLVLSAVFLPLAFMAGSVGVIYQQFSVSLAVSILFSGFLALTFTPALCATLFKPIPEGHHEKRGFFGAFNRGFARVTERYSLLNSKLVARAGRFMLVYAGLVAMLGYFYLRLPEAFVPAEDLGYMVVDVQLPPGASRVRTDATGEELERFLKSREAVASVFLISGFSFSGQGDNAALAFPTFKDWSERGAEQSSAAEIAALNEHFALPDDGTVMAVSPPPINGLGNSGGFALRLMDRSGVGREALLQARDTLLGEIQTNPKFLYAMMEGLAEAPQLRLLIDREKARALGVSFETISGTLSAAFGSEVINDFTNAGRQQRVVIQAEQGNRMTPESVLELYVPNAAGNLVPLSAFVSVKWEEGPVQLVRYNGYPSIRIVGDAAPGFSTGEAMAEMERLASQLPAGIGYEWTGLSYQEKVSAGQATSLFALAILVVFLLLVALYESWSIPLSVMLIVPIGAIGAVLAVMVSGMSNDVYFKVGLITIIGLSAKNAILIVEFAKELWEQGHSLRDAAIEAARLRFRPIIMTSMAFILGVIPLALASGAGAASQRAIGTGVIGGMLSATFLGVLFVPICFVWLLSLLRSKPAPIEQAASAGE	37.10	gnl|BL_ORD_ID|1485|hsp_num:0	1523			2025	2238	erythromycin; gentamicin C; tetracycline; novobiocin; trimethoprim; chloramphenicol; ofloxacin; gentamicin
